document type sequence filename description text html head title title head body bgcolor white style margin margin bottom font size font family time roman align right exhibit style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size font family time roman align justify confidential portion this document have been redacted have been separately filed with security exchange commission information that omitted edgar version been noted this document with placeholder identified mark style margin margin bottom font size font family time roman align center development license agreement style margin margin bottom font size font family time roman align center between style margin margin bottom font size font family time roman align center pfenex style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center hospira bahamas biologics style margin margin bottom font size font family time roman align center february nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style page break before always size style color width align center style margin margin bottom font size font family time roman align center table content style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nbsp valign bottom valign bottom colspan style border bottom solid page valign bottom nbsp style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman article definition valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman section defined term valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman article grant license valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman section commercialization license valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section sublicenses valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section implied license valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman article product development valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman section development effort valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section development plan valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section subcontracting research valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section research report record valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section regulatory effort valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section commitment activity valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section medical affair valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section compete valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman article payment valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman section upfront license payment valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section product milestone payment valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section sale milestone payment valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section royalty obligation valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section report valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section payment term valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman article manufacture product sale marketing valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman section manufacturing effort valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section tech transfer valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section manufacturing standard valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section product packaging labeling valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section product documentation valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section medical product complaint valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section product recall valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section maintenance registration reporting valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section regulatory inspection valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section product pricing promotion agency contact valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section reporting adverse drug reaction valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section sale marketing valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman article product trademark intellectual property litigation valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman section product trademark valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section ownership valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style page break before always size style color width align center style margin margin bottom font size font family time roman align center table content style margin margin bottom font size font family time roman align center continued style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nbsp valign bottom valign bottom colspan style border bottom solid page valign bottom nbsp style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman section patent prosecution maintenance valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section intellectual property strategy valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section manufacturing process valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section enforcement valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section reimbursement requirement valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section recovered amount valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section common interest agreement valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section confidentiality action valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section patent marking valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section article applicable valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman article executive steering committee valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman section formation purpose valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section membership valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section meeting requirement valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section decision making dispute resolution valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section meeting minute valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section expense valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section working committee valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section committee authority withdrawal valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section responsibility valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section cooperation valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman article viii confidentiality nonsolicitation valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman section confidentiality valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section agent valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section restriction sharing information valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section nonsolicitation valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman article representation warranty covenant valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman section representation warranty pfenex valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section representation warranty hospira valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section debarment covenant valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section disclaimer warranty valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section public announcement valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section insurance valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman article term termination dispute valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman section term valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section termination valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section general effect expiration termination valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section additional effect expiration certain hospira termination valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center table content style margin margin bottom font size font family time roman align center continued style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nbsp valign bottom valign bottom colspan style border bottom solid page valign bottom nbsp style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman section nbsp additional effect upon failure obtain regulatory approval valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section nbsp dispute valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman article indemnification liability limit valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman section nbsp indemnification pfenex valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section nbsp indemnification hospira valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section nbsp indemnification procedure valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section nbsp limitation liability valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section nbsp unavailability indemnification valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman article antitrust filing valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman section nbsp general valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman article xiii miscellaneous valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman section nbsp force majeure valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section nbsp notice valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section nbsp governing valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section nbsp arbitration valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section nbsp relationship party valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section nbsp assignment valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section nbsp binding effect valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section nbsp entire agreement amendment valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section nbsp severability valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section nbsp rule construction valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section nbsp waiver valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section nbsp counterpart valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section nbsp electronic execution delivery valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section nbsp license protection valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section nbsp further assurance valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section nbsp compliance with applicable valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section nbsp expense valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section nbsp third party beneficiary valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman section nbsp equitable remedy valign bottom valign bottom nbsp valign bottom align right nbsp nbsp nowrap valign bottom nbsp nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center development license agreement style margin margin bottom text indent font size font family time roman align justify this development license agreement this agreement entered into february nbsp signature date between pfenex delaware corporation pfenex hospira bahamas biologics company incorporated under bahamas hospira style margin margin bottom font size font family time roman align center witnesseth style margin margin bottom text indent font size font family time roman align justify whereas hospira expertise development distribution marketing commercialization pharmaceutical product human style margin margin bottom text indent font size font family time roman align justify whereas pfenex clinical stage biotechnology company engaged development difficult manufacture high value protein focusing biosimilar therapeutic including product hereinafter defined style margin margin bottom text indent font size font family time roman align justify whereas hospira wish obtain from pfenex pfenex wish grant hospira exclusive license develop manufacture commercialize promote market offer sale sell distribute product during term hereinafter defined term subject term condition forth herein style margin margin bottom text indent font size font family time roman align justify whereas simultaneously with execution this agreement hospira delaware corporation sole shareholder hospira parent entering into that certain guaranty agreement pursuant which among other thing will guarantee performance hospira obligation forth this agreement guaranty style margin margin bottom text indent font size font family time roman align justify therefore consideration mutual promise covenant agreement forth herein other good valuable consideration receipt sufficiency which hereby acknowledged pfenex hospira agree follows style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center definition style margin margin bottom text indent font size font family time roman align justify section nbsp defined term following word phrase when used herein with initial capital letter shall have meaning forth referenced below style margin margin bottom text indent font size font family time roman align justify acquiring entity mean third party that merges consolidates with acquires pfenex which pfenex transfer substantially asset which this agreement pertains acquisition transaction style margin margin bottom text indent font size font family time roman align justify action mean proceeding action claim formal informal including letter arbitration administrative regulatory action other type legal action whether taken plaintiff initiating party including through request declaratory judgment counter claim defense style margin margin bottom text indent font size font family time roman align justify meaning forth exhibit style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify adverse drug response shall defined more detail agreement include adverse drug response defined then current guideline regulation promulgated international conference harmonization technical requirement registration pharmaceutical human adverse drug experience defined then current section nbsp style margin margin bottom text indent font size font family time roman align justify affiliate mean corporation other business entity controlled controlling under common control with party purpose this definition control mean nbsp direct indirect beneficial ownership fifty percent nbsp more voting stock such corporation other business entity nbsp possession directly indirectly other power direct cause direction management policy such corporation other business entity whether through ownership voting security contract otherwise style margin margin bottom text indent font size font family time roman align justify agent meaning forth section style margin margin bottom text indent font size font family time roman align justify agreement meaning forth preamble this agreement style margin margin bottom text indent font size font family time roman align justify annual sale mean given annual period aggregate sale during such annual period style margin margin bottom text indent font size font family time roman align justify annual period mean nbsp period commencing effective date ending december nbsp date this agreement terminated such termination occurs prior december nbsp nbsp each successive calendar year during term other than calendar year which term expires this agreement terminated period beginning january nbsp style font size vertical align such year ending december nbsp style font size vertical align such year nbsp calendar year other than which term expires this agreement terminated period beginning january nbsp style font size vertical align such calendar year ending effective date expiration termination this agreement style margin margin bottom text indent font size font family time roman align justify applicable mean each applicable federal state local foreign constitution treaty statute ordinance rule regulation interpretation directive policy order writ award decree injunction judgment stay restraining order governmental authority regulatory agency term regulatory approval other ruling decision agreement with other requirement governmental authority including united state foreign corrupt practice other applicable united state united state anti corruption style margin margin bottom text indent font size font family time roman align justify assignee mean person other than pfenex hospira that assigned transferred succeeds right under this agreement style margin margin bottom text indent font size font family time roman align justify average sale price mean with respect particular country particular period weighted average sale price product bundled product other product service included bundled product applicable price determined dividing nbsp total gross sale invoiced commercial sale product bundled product other product service included bundled product length transaction applicable country during applicable period nbsp unit product bundled product other product service included style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify bundled product commercially sold length transaction such country during such period when determining gross sale product included bundled product methodology used allocate portion gross sale proceeds bundled product product forth definition sale shall used allocate gross sale proceeds product style margin margin bottom text indent font size font family time roman align justify biobetter mean with respect given biologic product proprietary second generation originator biologic product which nbsp reference given biologic product whether comparator otherwise nbsp same mechanism action given biologic product superior safety efficacy profile compared given biologic product nbsp approved intended approved through bpcia pathway united state similar pathway other jurisdiction style margin margin bottom text indent font size font family time roman align justify biosimilar mean with respect given biologic product another biologic product which differ clinically meaningful from given biologic product with respect amino acid sequence analytical comparability safety efficacy being developed approved more indication which given biologic product approved style margin margin bottom text indent font size font family time roman align justify mean biologic license application filed with under section nbsp public health service obtain regulatory approval product united state equivalent application regulatory agency obtain regulatory approval product outside united state style margin margin bottom text indent font size font family time roman align justify bpcia mean united state biologics price competition innovation including amendment thereto regulation promulgated thereunder style margin margin bottom text indent font size font family time roman align justify bundled product mean product sold together with other product service single unit price whether packaged together separately which other product service have material independent value from product itself style margin margin bottom text indent font size font family time roman align justify business mean research development manufacture commercialization product pfenex hospira their respective affiliate subcontractor either individually jointly including pursuant development program style margin margin bottom text indent font size font family time roman align justify business mean other than saturday sunday holiday which national banking association state illinois state california authorized applicable closed style margin margin bottom text indent font size font family time roman align justify cgmp mean then current good manufacturing practice quality system regulation forth regulatory agency country which product shall sold which drug substance product manufactured style margin margin bottom text indent font size font family time roman align justify cgxp mean then current good manufacturing clinical development laboratory practice quality system regulation applicable forth regulatory agency style margin margin bottom text indent font size font family time roman align justify code meaning forth definition fatca style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify commercial hourly rate mean hour provided that such amount will adjusted annual basis beginning january nbsp percentage increase decrease forth table employment cost index total compensation private industry worker occupational group industry seasonally adjusted category professional scientific technical service published united state department labor bureau based upon then most currently available annual percentage increase style margin margin bottom text indent font size font family time roman align justify commercialization license meaning forth section style margin margin bottom text indent font size font family time roman align justify commercially reasonable effort mean with respect activity conducted party with respect objective reasonable diligent good faith effort resource financial otherwise accomplish such objective such party would normally accomplish similar objective under similar circumstance style font size vertical align clarity understood that commercially reasonable effort shall evaluated both global basis country country basis based factor relevant such country including size market availability pricing strategy likelihood gray market good applicable likelihood regulatory approval expected change over time style margin margin bottom text indent font size font family time roman align justify commitment activity meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify commitment cost report meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify commitment cost meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify common interest agreement meaning forth section style margin margin bottom text indent font size font family time roman align justify comparative clinical study mean controlled study product administration product human being where principal purpose such study provide confirmatory comparative safety efficacy immunogenicity data necessary support filing regulatory approval product described more detail that certain memorandum exchanged between party signature date referencing this agreement style margin margin bottom text indent font size font family time roman align justify comparative clinical study cost invoice meaning forth section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify comparative clinical study cost report meaning forth section style margin margin bottom text indent font size font family time roman align justify comparative clinical study cost meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify competing activity meaning forth section style margin margin bottom text indent font size font family time roman align justify competing product shall mean product other than product that reference product biosimilar reference product biobetter reference product style margin margin bottom text indent font size font family time roman align justify competing product enforcement action meaning forth section style margin margin bottom text indent font size font family time roman align justify component mean drug substance material component component part labeling packaging both primary secondary ancillary good shipping material other item used manufacture supply product hereunder accordance with applicable product specification packaging specification style margin margin bottom text indent font size font family time roman align justify confidential information meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify confidentiality exception meaning forth section style margin margin bottom text indent font size font family time roman align justify control mean with respect particular know particular patent possession party granting applicable right license sublicense other party provided herein power authority whether arising ownership license other authorization disclose deliver particular know other party grant authorize under such know patent right license sublicense applicable scope granted such other party this agreement without giving rise violation term agreement other arrangement with right third party notwithstanding anything contrary this agreement following shall deemed controlled pfenex nbsp know patent owned licensed acquiring entity immediately prior effective date acquisition transaction nbsp know patent that acquiring entity subsequently develops without accessing practicing know patent owned licensed pfenex immediately prior effective date acquisition transaction existing pfenex technology provided however such know patent subsequently developed created acquiring entity from through access practice existing pfenex technology shall deemed controlled pfenex controlled shall have correlative meaning style margin margin bottom text indent font size font family time roman align justify controlling party meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify cooperating party meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify meaning forth exhibit style margin margin bottom text indent font size font family time roman align justify debarred entity person other than individual that been debarred pursuant nbsp another regulatory agency pursuant comparable statute from submitting assisting submission application style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify abbreviated other drug application generation preparation data with respect thereto affiliate such person style margin margin bottom text indent font size font family time roman align justify debarred individual mean individual been debarred pursuant nbsp another regulatory agency pursuant comparable statute from providing service capacity including generation preparation data person that approved pending drug application style margin margin bottom text indent font size font family time roman align justify designated product manufacturer meaning forth section style margin margin bottom text indent font size font family time roman align justify developing party meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify development plan meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify development program meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify dispute meaning forth section style margin margin bottom text indent font size font family time roman align justify divest meaning forth section style margin margin bottom text indent font size font family time roman align justify divestible asset meaning forth section style margin margin bottom text indent font size font family time roman align justify mean antitrust division united state department justice style margin margin bottom text indent font size font family time roman align justify technology assignment agreement mean that certain technology assignment agreement dated november nbsp between global technology chemical company pfenex style margin margin bottom text indent font size font family time roman align justify technology licensing agreement mean that certain technology licensing agreement dated november nbsp between global technology chemical company pfenex style margin margin bottom text indent font size font family time roman align justify drug substance mean that certain monoclonal antibody fragment described more detail that certain memorandum exchanged between party signature date referencing this agreement style margin margin bottom text indent font size font family time roman align justify effective date mean clearance date style margin margin bottom text indent font size font family time roman align justify mean european medicine agency style margin margin bottom text indent font size font family time roman align justify enforcement action meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify enforcing party meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify excess cost meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify executive steering committee meaning forth section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify existing pfenex technology meaning forth definition control style margin margin bottom text indent font size font family time roman align justify failure meet clinical endpoint mean more primary endpoint regulatory approval comparative clinical study product have achieved statistical significance determined alpha level specific statistical test primary secondary analysis population defined applicable final protocol applicable statistical analysis plan each amended from time time hospira accordance herewith through statistical analysis method specified applicable protocol amended from time time hospira accordance herewith analyzing product primary endpoint regulatory approval style margin margin bottom text indent font size font family time roman align justify fatca mean section through code date this agreement amended successor version that substantively comparable materially more onerous comply with current future regulation official interpretation thereof agreement entered into pursuant section nbsp code style margin margin bottom text indent font size font family time roman align justify mean united state food drug administration style margin margin bottom text indent font size font family time roman align justify first commercial sale mean first commercial sale third party invoiced hospira affiliate with respect product given country after receiving regulatory approval product such country style margin margin bottom text indent font size font family time roman align justify force majeure meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify mean united state federal trade commission style margin margin bottom text indent font size font family time roman align justify gaap mean with respect person united state generally accepted accounting principle consistently applied such person style margin margin bottom text indent font size font family time roman align justify governmental authority mean supranational national regional state provincial local other government other court competent jurisdiction legislature governmental administrative regulatory agency department body bureau council commission other supranational national regional state provincial local other governmental authority instrumentality including regulatory agency each case having jurisdiction country other jurisdiction style margin margin bottom text indent font size font family time roman align justify guaranty meaning forth recital this agreement style margin margin bottom text indent font size font family time roman align justify hospira meaning forth preamble this agreement style margin margin bottom text indent font size font family time roman align justify hospira indemnitees meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify hospira invention meaning forth section style margin margin bottom text indent font size font family time roman align justify hospira manufacturing license meaning forth section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify hospira technology mean nbsp know controlled hospira affiliate hospira nbsp patent controlled hospira affiliate style margin margin bottom text indent font size font family time roman align justify hospira knowledge mean actual knowledge after reasonable inquiry hospira nbsp vice president global pharmaceutical marketing nbsp senior director strategic marketing nbsp director global business development style margin margin bottom text indent font size font family time roman align justify mean united state hart scott rodino antitrust improvement amended rule regulation promulgated thereunder style margin margin bottom text indent font size font family time roman align justify clearance date mean earliest date which party have actual knowledge that applicable waiting period have expired have been terminated under with respect transaction contemplated under this agreement style margin margin bottom text indent font size font family time roman align justify filing meaning forth section style margin margin bottom text indent font size font family time roman align justify indemnification notice meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify indemnification objection meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify indemnified party meaning forth section style margin margin bottom text indent font size font family time roman align justify indemnified mean imposed result assignment transfer right under this agreement party assignee including merger liquidation reorganization other party assigning party payment under this agreement assigning party other than imposed with respect assigning party required withheld deducted from payment assigning party that nbsp imposed measured income however denominated franchise branch profit each case nbsp imposed result assigning party being organized under having principal office jurisdiction imposing such political subdivision thereof nbsp that imposed result present former connection between assigning party jurisdiction imposing such other than connection arising from assigning party having executed delivered become party performed obligation under received payment under received perfected security interest under engaged other transaction pursuant enforced this agreement nbsp attributable assigning party failure comply with section nbsp nbsp federal withholding imposed under fatca term indemnified shall also include penalty fine other additional statutory charge incidental related imposition otherwise indemnified extent caused omission assigning party style margin margin bottom text indent font size font family time roman align justify indemnify meaning forth section style margin margin bottom text indent font size font family time roman align justify indemnifying party meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify infringing activity meaning forth section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify initial development plan meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify initial term meaning forth section style margin margin bottom text indent font size font family time roman align justify intellectual property mean with respect person intellectual property confidential information proprietary information such person including nbsp patent nbsp trademark service mark trade dress trade name internet domain name assumed name entity name together with goodwill business associated with symbolized such trademark service mark trade dress trade name entity name each case whether registered nbsp published unpublished work authorship whether copyrightable including statutory common copyright associated therewith nbsp trade secret nbsp know style margin margin bottom text indent font size font family time roman align justify inventory sell down period meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify assertion notice meaning forth section style margin margin bottom text indent font size font family time roman align justify cost mean cost expense incurred paid including through reimbursement party payable party resulting from arising relating strategy action including attorney other legal expense cost expense opinion advice counseling consultant expert expense court cost amount paid payable settlement satisfaction judgment with respect strategy action including damage lump payment periodic payment going royalty payment other type payment required enable resulting from marketing promotion manufacture sale product result strategy action style margin margin bottom text indent font size font family time roman align justify strategy meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify joint invention meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify joint patent meaning forth section style margin margin bottom text indent font size font family time roman align justify know mean technical information material tangible intangible form whatsoever including without limitation technology report database data result bacterial strain genetic construct genomic sequence annotation analytical model computer software algorithm controlling fermentation vessel related equipment chemical invention patentable otherwise practice method knowledge technique specification formulation formula know skill experience test data including pharmacological biological chemical biochemical toxicological clinical test data analytical quality control data stability data study procedure patent other legal information description provided however that know shall exclude patent style margin margin bottom text indent font size font family time roman align justify last dosed patient date mean with respect comparative clinical study date upon which last patient receives final dosing with respect protocol such study style margin margin bottom text indent font size font family time roman align justify lien mean lien claim charge pledge security interest other encumbrance nature whatsoever style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify loss meaning forth section style margin margin bottom text indent font size font family time roman align justify major market mean each country forth exhibit style margin margin bottom text indent font size font family time roman align justify manufacturing action meaning forth section style margin margin bottom text indent font size font family time roman align justify manufacturing process development mean development initial manufacturing process analytical method process final quality control quality assurance protocol method support manufacture including release product using manufacturing strain clarity manufacturing process development includes manufacturing experience pfenex with respect product including signature date style margin margin bottom text indent font size font family time roman align justify manufacturing strain mean production strain that express drug substance which developed pfenex using pfenex expression technology prior effective date described more detail that certain memorandum exchanged between party signature date referencing this agreement such other production strain that express drug substance that pfenex develop replace supplement existing production strain provided that such replacement supplement must first approved hospira style margin margin bottom text indent font size font family time roman align justify medical affair strategy meaning forth section style margin margin bottom text indent font size font family time roman align justify sale mean specified period gross sale received hospira affiliate sale transfer product hospira affiliate affiliate hospira during such period following deduction extent charged part invoiced price separately stated invoice calculated function invoice price without duplication extent reimbursed third party style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp credit allowance return account third party spoiled damaged outdated rejected recalled returned unit product style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp cash quantity trade discount rebate wholesaler group purchasing organization chargebacks third party extent actually allowed taken directly third party with respect sale product style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp sale value added other direct indirect extent billed paid third party style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp transportation insurance cost custom duty surcharge other governmental charge other handling expense incurred connection with transportation exportation importation unit product style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp management group purchasing organization wholesaler similar compensation commercialization service provider specialty pharmacy home delivery service each case with respect product actually paid payable style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp medicaid other government rebate program including supplemental rebate style margin margin bottom text indent font size font family time roman align justify avoidance doubt nbsp deduction described nbsp inclusive shall exclude amount included within selling general administrative expense hospira affiliate accordance with gaap nbsp product that provided sample connection with compassionate program invoiced therefore subject definition sale commercial sale purpose this agreement shall taken into account determining average sale price style margin margin bottom text indent font size font family time roman align justify style font size vertical align style margin margin bottom text indent font size font family time roman align justify case sale transfer product affiliate other than transaction exclusively cash sale amount unit shall deemed average sale price calendar quarter which such sale transfer took place style margin margin bottom text indent font size font family time roman align justify with respect bundled product sale such bundled product shall first calculated accordance with definition sale above then sale product included such bundled product shall determined follows style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp multiply sale such bundled product fraction where average sale price product included such bundled product when sold separately total average sale price each other product service included such bundled product when sold separately style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp average sale price product included such bundled product determined average sale price other product service included such bundled product determined then multiply sale such bundled product fraction where average sale price product when sold separately average sale price such bundled product style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp average sale price product included such bundled product available such period nbsp product included such bundled product sold separately material number then multiply sale such bundled product percentage reasonably determined mutual agreement hospira pfenex that represents proportionate economic value product included such bundled product relative economic value contributed other product service included such bundled product style margin margin bottom text indent font size font family time roman align justify neutral meaning forth exhibit style margin margin bottom text indent font size font family time roman align justify assigning party meaning forth definition indemnified style margin margin bottom text indent font size font family time roman align justify notifying party meaning forth section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify election notice meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify opportunity meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify opportunity notice meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify strategy action meaning forth section style margin margin bottom text indent font size font family time roman align justify ophthalmic biological product mean biological product protein including antibody fragment thereof peptide that mean inhibition biologic activity human vascular endothelial growth factor vegf other than product bevacizumab biobetter bevacizumab biosimilar bevacizumab competing product labeled treatment retinal disease condition style margin margin bottom text indent font size font family time roman align justify other party meaning forth section style margin margin bottom text indent font size font family time roman align justify style font size vertical align style margin margin bottom text indent font size font family time roman align justify packaging specification mean those packaging labeling branding specification product style margin margin bottom text indent font size font family time roman align justify parent meaning forth recital this agreement style margin margin bottom text indent font size font family time roman align justify party mean hospira pfenex style margin margin bottom text indent font size font family time roman align justify party mean either hospira pfenex style margin margin bottom text indent font size font family time roman align justify patent mean following whether existing future anywhere world nbsp issued patent including inventor certificate substitution extension confirmation reissue reexamination renewal like governmental grant protection invention nbsp pending application foregoing including continuation divisional substitution continuation part provisional converted provisional application style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify person mean individual partnership limited liability company corporation association joint stock company trust joint venture unincorporated organization governmental authority other entity kind style margin margin bottom text indent font size font family time roman align justify pfenex meaning forth preamble this agreement style margin margin bottom text indent font size font family time roman align justify pfenex expression technology mean pfenex proprietary pseudomonas fluorescens expression platform technology used development production strain produce biological product including through optimization nucleic acid sequence together with intellectual property related thereto including intellectual property including patent transferred licensed pfenex under technology assignment agreement technology licensing agreement style margin margin bottom text indent font size font family time roman align justify pfenex indemnitees meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify pfenex invention meaning forth section style margin margin bottom text indent font size font family time roman align justify pfenex know mean know controlled pfenex affiliate pfenex useful operation business including conduct portion development plan assigned pfenex manufacture product know relating manufacturing strain style margin margin bottom text indent font size font family time roman align justify pfenex patent mean current future patent controlled pfenex affiliate nbsp claiming composition drug substance product nbsp claiming method process manufacture drug substance product nbsp claiming method administration formulation drug substance product nbsp claiming manufacturing strain including composition thereof list current pfenex patent forth that certain memorandum exchanged between party signature date referencing this agreement style margin margin bottom text indent font size font family time roman align justify pfenex share commitment cost meaning forth section style margin margin bottom text indent font size font family time roman align justify pfenex technology mean pfenex know pfenex patent manufacturing strain pfenex invention pfenex right joint invention pfenex right joint patent excluding pfenex expression technology style margin margin bottom text indent font size font family time roman align justify pfenex knowledge known pfenex mean actual knowledge after reasonable inquiry pfenex nbsp chief financial officer nbsp chief business officer nbsp chief medical officer style margin margin bottom text indent font size font family time roman align justify pharmacokinetic study mean clinical trial product utilizing limited number human being address comparative pharmacokinetics pharmacodynamics safety described more detail that certain memorandum exchanged between party signature date referencing this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify phase study mean human clinical study product conducted after product receives first regulatory approval required applicable regulatory agency condition such regulatory approval style margin margin bottom text indent font size font family time roman align justify post execution other business meaning forth section style margin margin bottom text indent font size font family time roman align justify clinical study mean vitro vivo other than human experiment preliminary safety tolerability including obtaining preliminary pharmacodynamics pharmacokinetic information with respect product style margin margin bottom text indent font size font family time roman align justify previous milestone event meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify prior agreement meaning forth section style margin margin bottom text indent font size font family time roman align justify proceeding mean claim action suit arbitration proceeding before otherwise involving governmental authority arbitral body style margin margin bottom text indent font size font family time roman align justify product mean biological pharmaceutical product final packaged form consisting drug substance style margin margin bottom text indent font size font family time roman align justify product complaint meaning forth section style margin margin bottom text indent font size font family time roman align justify product data sheet mean that certain document agreed party forth that certain memorandum exchanged between party signature date referencing this agreement which contains target product profile designates research development commercialization hereunder specified indication forth minimum data needed support section target product profile product which consistent with applicable package insert reference product applicable jurisdiction style margin margin bottom text indent font size font family time roman align justify product documentation mean marketing promotional literature packaging insert including patient information leaflet customer documentation applicable product style margin margin bottom text indent font size font family time roman align justify product specification mean those product performance specification product including product formula material required manufacture product style margin margin bottom text indent font size font family time roman align justify product trademark meaning forth section style margin margin bottom text indent font size font family time roman align justify program related cost mean direct indirect cost expense paid third party pfenex hospira development program each case extent recorded such accordance with pfenex hospira case internal accounting practice applied consistent basis style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify prosecution maintenance mean with regard patent preparing filing prosecuting maintenance such patent well examination reissue request patent term extension like with respect such patent together with conduct interference defense opposition other similar proceeding with respect particular patent style margin margin bottom text indent font size font family time roman align justify agreement meaning forth section style margin margin bottom text indent font size font family time roman align justify quarterly period mean three nbsp month period each calendar year ending march nbsp nbsp june nbsp nbsp september nbsp december nbsp except that first quarterly period shall period commencing effective date ending march nbsp style margin margin bottom text indent font size font family time roman align justify reference product mean lucentis style font size vertical align ranibizumab approved applicable jurisdiction style margin margin bottom text indent font size font family time roman align justify registration mean permit license approval authorization granted regulatory agency with respect product including manufacture handling storage import transport distribution sale thereof style margin margin bottom text indent font size font family time roman align justify regulatory agency mean federal state local regulatory agency department bureau other governmental authority united state canada european union other country applicable including health canada each case that responsible registration necessary otherwise governs manufacture handling storage import transport distribution sale product style margin margin bottom text indent font size font family time roman align justify regulatory approval mean with respect product given country necessary registration from applicable regulatory agency such country manufacture store import transport market promote sell place market product such country style margin margin bottom text indent font size font family time roman align justify regulatory approval cost report meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify regulatory approval cost meaning forth section style margin margin bottom text indent font size font family time roman align justify regulatory approval milestone event meaning forth section style margin margin bottom text indent font size font family time roman align justify regulatory material mean regulatory application including blas submission notification communication correspondence registration regulatory approval other filing made received from otherwise conducted with regulatory agency including minute meeting with regulatory agency that necessary otherwise relate development manufacture commercialization product style margin margin bottom text indent font size font family time roman align justify meaning forth section style margin margin bottom text indent font size font family time roman align justify signature date meaning forth preamble this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify solicitation action meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify soliciting party meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify standstill period meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify subcontractor meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify subject record meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify subject transaction meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify subsequent term meaning forth section style margin margin bottom text indent font size font family time roman align justify successful completion comparative clinical study mean completion comparative clinical study product where there been failure meet clinical endpoint provided that applicable regulatory agency provided written notice within nbsp month following completion such study that further clinical trial will required obtain regulatory approval style margin margin bottom text indent font size font family time roman align justify mean duty impost charge withholding rate levy other governmental imposition other kind whatsoever imposed assessed charged style margin margin bottom text indent font size font family time roman align justify indemnified party meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify indemnifying party meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify taxing authority mean governmental authority responsible imposition assessment collection style margin margin bottom text indent font size font family time roman align justify technical transfer plan meaning forth section style margin margin bottom text indent font size font family time roman align justify term meaning forth section style margin margin bottom text indent font size font family time roman align justify third party mean person other than party such party affiliate style margin margin bottom text indent font size font family time roman align justify third party claim meaning forth section style margin margin bottom text indent font size font family time roman align justify transfer meaning forth section style margin margin bottom text indent font size font family time roman align justify united state mean united state america including district columbia puerto rico other territory possession united state america style margin margin bottom text indent font size font family time roman align justify working committee meaning forth section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center grant license style margin margin bottom text indent font size font family time roman align justify section nbsp commercialization license subject term condition this agreement pfenex hereby grant hospira worldwide exclusive even pfenex except allow pfenex perform obligation under term this agreement transferable solely accordance with section nbsp sublicenseable subject provision section nbsp license pfenex technology conduct portion development plan assigned hospira manufacture commercialize promote market offer sale sell distribute product during term commercialization license connection therewith hospira whether itself through affiliate shall except otherwise expressly provided herein have sole authority responsibility development regulatory approval commercialization product including regulatory compliance manufacturing marketing clinical development distribution sale pricing product liability payer reimbursement return discount charge back rebate with respect thereto clarity commercialization license include right hospira modify manufacturing strain authorize third party without prior written consent pfenex style margin margin bottom text indent font size font family time roman align justify section nbsp nbsp nbsp nbsp nbsp sublicenses style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp commercialization license includes right sublicense within scope thereof each major market hospira affiliate shall nbsp book sale product accordance with hospira affiliate ordinary course business nbsp remain primarily responsible marketing promotion product each major market which will under trademark controlled hospira affiliate style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp hospira shall promptly notify pfenex grant each sublicense provide pfenex copy final executed sublicense agreement including provision necessary determining style font size vertical align redacted information pertinent this agreement style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp hospira shall responsible failure sublicensees comply with relevant restriction limitation obligation this agreement style margin margin bottom text indent font size font family time roman align justify section nbsp implied license each party acknowledges that right license granted under this article elsewhere this agreement limited scope expressly granted accordingly except right expressly granted under this agreement right title interest nature whatsoever granted whether implication estoppel reliance otherwise either party other party without limiting obligation hereunder including exclusivity forth section nbsp right with respect know patent other intellectual property right that specifically granted herein reserved owner thereof hospira agrees that neither affiliate will otherwise exploit pfenex technology except expressly licensed permitted this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center product development style margin margin bottom text indent font size font family time roman align justify section nbsp nbsp nbsp nbsp nbsp development effort style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp pfenex responsibility pfenex shall perform responsibility forth development plan including nbsp completion expense pharmacokinetic study nbsp using commercially reasonable effort perform manufacturing process development work described development plan pfenex shall upon request hospira provide hospira with record document data other information related development with respect product including manufacturing process development work clinical study conducted behalf pfenex with respect product either before after date hereof each case reasonably requested hospira conduct obligation exercise right hereunder pfenex shall conduct activity performance development program good scientific manner using cgxp applicable jurisdiction where obligation under development program being conducted extent cgxps applicable activity achieve objective development program efficiently expeditiously compliance with applicable pfenex shall cooperate provide hospira with reasonable assistance connection with performance hospira obligation under section nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp hospira responsibility approval hospira shall commercially reasonable effort perform responsibility forth development plan including nbsp developing product solely indication forth product data sheet accordance with development plan nbsp conducting completing comparative clinical study subject reimbursement obligation forth section nbsp hospira shall conduct activity performance development program good scientific manner using cgxp applicable jurisdiction where development program being conducted extent such cgxps applicable activity achieve objective development program efficiently expeditiously compliance with applicable hospira shall keep pfenex reasonably informed hospira affiliate progress development regulatory activity relating product update executive steering committee meeting style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp reimbursement comparative clinical study cost except forth this agreement hospira conduct development activity with respect product shall expense pfenex shall reimburse hospira fifty percent nbsp documented amount actually paid hospira third party conduct comparative clinical study with respect product accordance with development plan total amount paid hospira comparative clinical study cost provided that aggregate reimbursement amount which hospira shall entitled with respect comparative clinical study cost shall exceed twenty million dollar understood that comparative clinical study cost shall include employee related expense hospira affiliate which between hospira pfenex shall sole responsibility hospira commencing date hereof continuing until comparative clinical study cost exceed aggregate amount equal forty million dollar hospira shall style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify furnish pfenex written report comparative clinical study cost report within sixty nbsp after each quarterly period setting forth amount comparative clinical study cost paid hospira such quarterly period each case together with such other documentation comparative clinical study cost reasonably requested pfenex until comparative clinical study cost exceed forty million dollar together with such comparative clinical study cost report hospira shall deliver pfenex written invoice fifty percent nbsp such comparative clinical study cost paid hospira such quarterly period comparative clinical study cost invoice pfenex shall hospira amount disputed good faith forth comparative clinical study cost invoice within thirty nbsp after pfenex receipt comparative clinical study cost report disputed amount shall paid within fifteen nbsp after resolution such dispute pursuant section provided that with respect portion comparative clinical study cost reimbursed pfenex exceeding million dollar above million dollar exceeding twenty million dollar excess cost pfenex shall such excess cost nbsp pursuant offset hospira royalty otherwise payable pfenex forth section nbsp nbsp applicable forth section style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp protocol comparative clinical study hospira shall provide pfenex through executive steering committee reasonable opportunity review comment upon draft protocol comparative clinical study amendment thereto such comment shall made pfenex soon practical event within fifteen nbsp from date pfenex receives copy draft protocol amendment executive steering committee shall have right determine finalize protocol comparative clinical study provided that executive steering committee hospira exercise ability finally resolve matter related clinical trial protocol product pursuant section nbsp shall consider good faith pfenex comment with respect thereto style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp manufacturing strain engineering hospira request that pfenex perform additional engineering manufacturing strain develop modified manufacturing strain each case using pfenex expression technology order manufacture product hereunder meet requirement market otherwise make product competitive market with respect change that arise after effective date then party agree negotiate good faith term condition pursuant which pfenex would perform such additional engineering development hereunder style margin margin bottom text indent font size font family time roman align justify section nbsp nbsp nbsp nbsp nbsp development plan style margin margin bottom text indent font size font family time roman align justify plan development product agreed party including timeline therein forth that certain memorandum exchanged between party signature date referencing this agreement such plan forth memorandum initial development plan together with update thereto accordance herewith development plan conduct activity under development plan development program development plan includes nbsp each party responsibility those activity performed regard obtaining regulatory approval product including timeline initiation completion such activity style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify annual budgeted program related cost product each annual period nbsp target date submission application other regulatory material regulatory approval product each major market pfenex hospira shall cooperate with another update amend development plan product data sheet from time time request party such party submission proposed amendment executive steering committee within nbsp business following submission party such proposed amendment development plan product data sheet executive steering committee shall decide whether approve such amendment modified version thereof notwithstanding above hospira shall have right make update amendment initial development plan updated development plan without submitting such change executive steering committee long such update amendment result delay finish date critical task defined that certain memorandum exchanged between party signature date referencing this agreement party shall refer most current development plan when identifying applicable finish date with respect critical task event hospira shall promptly notify project lead development program pfenex such update amendment such notice provided email project lead except forth this section nbsp neither development plan product data sheet amended without prior documented approval executive steering committee subject limitation hospira final decision making authority forth section nbsp below style margin margin bottom text indent font size font family time roman align justify hospira shall have right exercise final decision making authority within executive steering committee with respect amendment development plan manner nbsp that would cause material delay timeline forth initial development plan clarity timeline initial development plan particular activity shall subject extension matter beyond reasonable control party responsible particular activity delay related clinical hold regulatory agency provided that such party commercially reasonable effort mitigate such delay such extension shall limited period necessary accommodate such delay nbsp that inconsistent term this agreement nbsp that would unilaterally impose material obligation pfenex including causing pfenex incur share cost that provided development plan this agreement date hereof provided that pfenex shall unreasonably withhold condition delay consent perform activity requested hospira that necessary useful development product pfenex unique position being able perform such activity hospira agrees reimburse pfenex internal external cost incurred connection with performance such activity which case internal cost shall determined accordance with gaap style margin margin bottom text indent font size font family time roman align justify section nbsp subcontracting each pfenex hospira subcontract affiliate third party each subcontractor portion responsibility under this agreement including development plan each subcontractor shall enter into customary confidentiality agreement other agreement with party engaging such subcontractor pursuant which such subcontractor shall nbsp bound obligation confidentiality with respect confidential information other party development plan development program least protective obligation forth section nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify through section nbsp nbsp bound obligation with respect technology intellectual property sufficient enable engaging party comply with term condition this agreement such engaging party completed such subcontracted activity itself nbsp required make representation warranty with respect debarment comparable representation warranty made party engaging such subcontractor under section section nbsp this agreement applicable nbsp obligated provide notice party engaging such subcontractor upon becoming subject investigation debarment proceeding that could lead such subcontractor becoming debarred entity debarred individual nbsp required comply with applicable including applicable conducting development program good scientific manner using cgxp party engaging such subcontractor shall supervise responsible under this agreement work each such subcontractor subcontracting obligation activity under this agreement shall relieve engaging party obligation responsibility hereunder style margin margin bottom text indent font size font family time roman align justify section nbsp report record audit right each pfenex hospira shall shall cause each subcontractor engaged such party pursuant section nbsp maintain complete accurate book record sufficient detail good scientific manner appropriate patent regulatory purpose when applicable purpose demonstrating compliance with term hereof that fully properly reflect work done result achieved program related cost expended performance development program which support calculation amount owed other party pursuant this term this agreement subject record each pfenex hospira shall retain subject record period least five nbsp year such longer period extent required applicable during such period upon written request either pfenex hospira subject record other each subcontractor engaged such other party shall subject inspection audit expense requesting party more than time annual period such audit shall occur upon reasonable notice during normal business hour independent auditor selected auditing party reasonably acceptable other party auditing party shall treat information received subject review under this section nbsp confidential information accordance with provision article viii auditing party shall cause independent auditor enter into confidentiality agreement form substance reasonably acceptable other party maintain such record information such other party confidence accordance with article viii such record information except extent permitted this agreement including enforcement provision hereof style margin margin bottom text indent font size font family time roman align justify section nbsp nbsp nbsp nbsp nbsp regulatory effort style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp filing regulatory approval following successful completion comparative clinical study with respect product hospira shall commercially reasonable effort obtain maintain solely name name affiliate subject section nbsp cost regulatory approval product each major market including using commercially reasonable effort perform those activity assigned hospira under development plan accordance with timeline therefor style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp reimbursement regulatory approval cost hospira shall furnish pfenex written report regulatory approval cost report within sixty nbsp after each quarterly period setting forth amount application approval actually paid hospira applicable regulatory agency applicable regulatory approval product under prescription drug user foreign equivalent regulatory approval cost paid hospira such quarterly period each case together with such other documentation regulatory approval cost reasonably requested pfenex clarity regulatory approval cost exclude annual other maintenance with respect regulatory approval paid payable after approval registration thereof pfenex dispute good faith amount forth regulatory approval cost report within thirty nbsp after pfenex receipt regulatory approval cost report such dispute shall subject provision section pfenex shall hospira fifty percent nbsp regulatory approval cost forth each regulatory approval cost report within thirty nbsp after pfenex receipt such report case dispute within fifteen nbsp resolution such dispute style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp ownership regulatory approval regulatory cooperation hospira shall solely regulatory approval with respect product shall have right control filing submission regulatory material order obtain maintain such regulatory approval accordance with section nbsp subject oversight consultation with executive steering committee accordingly prior filing regulatory material including product hospira shall provide copy thereof pfenex through executive steering committee review comment pfenex shall have nbsp business from date pfenex receives copy regulatory material provide comment such regulatory material hospira shall consider such comment good faith hospira shall responsible liaising with managing interaction with regulatory agency with respect product provided that hospira shall extent permitted applicable provide pfenex nbsp reasonable advanced notice event than five nbsp business advance notice whenever feasible substantive meeting with regulatory agency that either scheduled with initiated behalf hospira affiliate nbsp opportunity have reasonable number least nbsp representative participate substantive meeting with regulatory agency case shall keep pfenex informed material interaction with regulatory agency provided that upon hospira request expense pfenex shall provide nbsp representative participate meeting with regulatory agency nbsp copy material document information correspondence submitted regulatory agency soon reasonably practicable style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp pfenex regulatory material extent permitted applicable necessary helpful obtain maintain regulatory approval product hospira shall have right refer reasonably rely upon filing regulatory approval with regulatory agency nbsp regulatory filing nbsp regulatory approval nbsp document information data contained such filing approval which have been used filed produced pfenex regulatory agency with respect product pfenex technology pfenex shall submit file with applicable regulatory style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify agency document necessary advisable transfer transferable grant hospira such right such filing approval document information data subject each case requirement restriction applicable regulatory agency style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp pfenex assistance pfenex shall cooperate provide hospira with reasonable assistance connection with performance hospira obligation under this section nbsp connection therewith pfenex shall provide hospira product dossier other pfenex know nbsp reasonably requested hospira nbsp within initial development plan scope established effective date further modification development plan approved executive steering committee nbsp necessary apply obtain regulatory approval product hospira shall entitled such dossier other pfenex know accordance therewith style margin margin bottom text indent font size font family time roman align justify section nbsp commitment activity style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp commitment activity hospira responsibility hospira shall have exclusive right control shall commercially reasonable effort conduct nbsp study product that hospira agrees with regulatory agency conduct condition regulatory approval such regulatory agency which study initiated after filing regulatory approval nbsp post marketing surveillance study data collection analysis with respect product nbsp pharmacovigilance activity nbsp medical investigation evaluation reporting adverse event related product each case nbsp nbsp required regulatory agency jurisdiction which hospira obtained regulatory approval with respect product collectively commitment activity clarity commitment activity exclude phase study hospira shall bear expense subject reimbursement obligation forth section nbsp commitment activity style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp offset commitment cost until documented amount paid hospira third party conduct commitment activity with respect product commitment cost exceed aggregate amount equal style font size vertical align hospira shall furnish pfenex written report commitment cost report within sixty nbsp after each quarterly period setting forth commitment cost paid hospira such quarterly period each case together with such other documentation commitment cost reasonably requested pfenex pfenex dispute good faith amount forth commitment cost report within thirty nbsp after pfenex receipt commitment cost report such dispute shall subject provision section pfenex shall reimburse style font size vertical align commitment cost total style font size vertical align pfenex share commitment cost nbsp pursuant offset hospira royalty otherwise payable pfenex forth section nbsp nbsp applicable forth section nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp pfenex assistance pfenex shall cooperate provide hospira with reasonable assistance connection with performance hospira obligation under this section nbsp including providing hospira full reasonable access clinical trial site record document data other information related clinical trial study conducted behalf pfenex hereunder including protocol statistical analysis plan final csrs clinical style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify trial enrollment progress result data generated scientific study memorialized laboratory notebook with respect product style margin margin bottom text indent font size font family time roman align justify section nbsp medical affair style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp medical affair strategy hospira shall have exclusive right control shall commercially reasonable effort conduct comprehensive strategy medical affair matter relating product medical affair strategy including with respect nbsp preparation publication based data other information relating trial study with respect product nbsp planning implementation congress participation medical education opinion leader advisory board meeting with respect product except otherwise forth herein hospira shall bear expense with respect medical affair strategy style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp pfenex assistance pfenex shall cooperate provide hospira with reasonable assistance connection with performance hospira obligation under this section nbsp style margin margin bottom text indent font size font family time roman align justify section nbsp compete style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp hospira compete notwithstanding anything contained herein contrary neither hospira affiliate shall directly indirectly itself through affiliate otherwise nbsp nbsp research develop obtain regulatory approval take action directed thereto manufacture competing product during period beginning effective date expiring later fifth style font size vertical align nbsp anniversary effective date first commercial sale major market standstill period nbsp market import offer sale sell otherwise commercialize including through distributor other third party competing product time during term nbsp authorize assist third party foregoing provided however that hospira affiliate time manufacture competing product length service contract manufacturing basis behalf more third party being understood such activity shall utilize pfenex technology pfenex expression technology avoidance doubt hospira shall limited prohibited this agreement from nbsp researching developing obtaining regulatory approval taking action directed thereto manufacturing competing product after expiration standstill period commercially marketing selling competing product following expiration earlier termination term taking action whatsoever with respect product other than product competing product style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp pfenex compete notwithstanding anything contained herein contrary neither pfenex affiliate shall directly indirectly itself through affiliate otherwise nbsp research develop obtain regulatory approval take action directed thereto manufacture nbsp competing product during standstill period nbsp reference product biosimilar reference product time thereafter during remainder term nbsp market import offer sale sell otherwise commercialize including through distributor other third party competing product time during style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify term nbsp authorize assist third party foregoing avoidance doubt pfenex shall limited prohibited this agreement from nbsp commercially marketing selling competing product following expiration earlier termination term research develop obtain regulatory approval take action directed thereto manufacture biobetter reference product after expiration standstill period taking action whatsoever with respect product other than product competing product style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp ophthalmic biological product prior party affiliate such party developing party engaging following activity either alone with third party nbsp clinically developing conducting human clinical study nbsp obtaining regulatory approval taking action directed thereto nbsp manufacturing nbsp marketing nbsp importing nbsp offering sale nbsp selling nbsp otherwise commercializing including through distributor other third party ophthalmic biological product nbsp developing party shall notify other party thereof setting forth status such ophthalmic biological product plan with respect thereto each opportunity together with other information possession material other party decision whether participate therein subject section nbsp through section nbsp each opportunity notice nbsp upon other party election participate such opportunity provided within thirty nbsp receipt opportunity notice election notice party shall meet soon practicable thereafter negotiate good faith definitive agreement pursuant which other party would have right participate opportunity connection with opportunity style font size vertical align other party fails deliver election notice developing party within applicable period other party elect participate opportunity after delivering election notice then developing party shall thereafter free pursue opportunity described opportunity notice without participation other party being understood that developing party have obligation offer opportunity other party again thereafter each party shall otherwise remain subject term this section without limiting other obligation forth herein each opportunity notice election notice shall writing reference this section nbsp provided pursuant requirement section nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp post effective date affiliate event party enters into transaction subject transaction whereby third party that engaged activity that would otherwise prohibited section nbsp nbsp competing activity becomes affiliate such party merges with such party such affiliate event merger portion business which party business immediately prior subject transaction each such case post execution other business then such party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify notifying party shall provide notice other party other party within five nbsp business closing subject transaction specifying identity post execution other business describing reasonable detail extent permitted without disclosing proprietary information competing activity their focus such notice shall also state whether notifying party elect nbsp divest competing activity nbsp hospira notifying party assign right obligation under this agreement third party such assignment shall require prior written consent pfenex pursuant section nbsp provided that such third party either nbsp market capitalization least five nbsp billion dollar sale force that will sell product least large sale force that hospira time such assignment nbsp been approved acquiror hospira right obligation under this agreement connection with divestiture asset nbsp keep separate competing activity included within activity under this agreement nbsp cease engaging competing activity within ninety nbsp following consummation subject transaction provided that style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp notifying party shall have right make election described under clause nbsp above forty percent nbsp more post execution other business business immediately prior subject transaction consists competing activity measured percentage both research development spend revenue with respect competing activity when compared research development spend revenue applicable post execution other business total trailing twelve month period ending upon consummation subject transaction style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp event notifying party elect option described clause nbsp above then nbsp notifying party shall have right exercise right fulfill obligation hereunder through such post execution other business such post execution other business shall receive license other right under pfenex technology competing activity other party shall have license under patent know controlled post execution other business that licensed other party prior subject transaction notifying party shall maintain capacity resource that reasonably necessary notifying party fulfill obligation hereunder extent notifying party required maintain such capacity resource subject transaction occurred nbsp notifying party shall commercially reasonable effort procedure mechanism place separate activity under this agreement competing activity including preventing disclosure confidential information other party post execution other business prevent receipt activity under agreement technology proprietary information post execution other business style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp event notifying party elect option described clause nbsp nbsp above then notifying party shall divest competing activity right obligation under this agreement applicable divestible asset soon reasonably practicable following subject transaction purpose this section nbsp divest mean with respect divestible asset nbsp sale exclusive license other transfer right title interest such divestible asset including style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify technology intellectual property other asset relating solely thereto third party other than post execution other business without retention reservation right license interest other than solely economic other customary termination interest notifying party post execution other business such divestible asset nbsp complete shutdown divestible asset such that technology intellectual property other asset solely relating thereto used notifying party affiliate delivery written confirmation from notifying party other party that notifying party affiliate covenant technology intellectual property asset solely relating such divestible asset during term this agreement style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center payment style margin margin bottom text indent font size font family time roman align justify section nbsp upfront license payment hospira shall pfenex time upfront license payment aggregate amount equal fifty million dollar such amount paid before fifth style font size vertical align nbsp business after effective date style margin margin bottom text indent font size font family time roman align justify section nbsp product milestone payment consideration hospira right under this agreement hospira shall pfenex style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp style font size vertical align immediately available fund within thirty nbsp following style font size vertical align style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp style font size vertical align immediately available fund within thirty nbsp following style font size vertical align style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp style font size vertical align immediately available fund within thirty nbsp following style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp style font size vertical align immediately available fund within thirty nbsp following style margin margin bottom text indent font size font family time roman align justify avoidance doubt each foregoing milestone payment forth clause nbsp through nbsp shall only paid once hospira such that maximum amount paid pursuant this section nbsp shall thirty million dollar style font size vertical align style margin margin bottom text indent font size font family time roman align justify clarity regulatory approval milestone event achieved previous milestone event product been achieved reason notwithstanding anything herein contrary such previous milestone event shall deemed have been achieved corresponding milestone payment forth above shall payable simultaneous with milestone payment achievement regulatory approval milestone event purpose foregoing each milestone event this section nbsp through nbsp shall deemed previous milestone event style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify section nbsp sale milestone payment consideration hospira right under this agreement hospira shall pfenex style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp style font size vertical align immediately available fund within sixty nbsp following quarterly period which annual sale product during applicable annual period first exceed style font size vertical align style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp style font size vertical align immediately available fund within sixty nbsp following quarterly period which annual sale product during applicable annual period first exceed style font size vertical align style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp style font size vertical align immediately available fund within sixty nbsp following quarterly period which annual sale product during applicable annual period first exceed style font size vertical align style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp style font size vertical align immediately available fund within sixty nbsp following quarterly period which annual sale product during applicable annual period first exceed style font size vertical align style margin margin bottom text indent font size font family time roman align justify avoidance doubt nbsp each foregoing milestone payment forth clause nbsp through nbsp shall only paid once hospira such that maximum amount paid pursuant this section nbsp shall hundred sixty million dollar style font size vertical align nbsp more than milestone event this section nbsp achieved particular quarterly period corresponding milestone payment such milestone event achieved such quarterly period shall style margin margin bottom text indent font size font family time roman align justify section nbsp royalty obligation style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp subject section nbsp commencing date which first commercial sale with respect product occurs continuing long there sale hospira shall pfenex royalty each quarterly period given annual period amount equal style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp aggregate style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp annual sale product during such annual period annual sale than equal plus style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp style font size vertical align annual sale product during such annual period that portion annual sale greater than than equal style font size vertical align plus style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp style font size vertical align annual sale product during such annual period that portion annual sale greater than style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp aggregate amount royalty payment paid under this section nbsp hospira pfenex preceding quarterly period during such annual period style margin margin bottom text indent font size font family time roman align justify style font size vertical align style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp hospira offset nbsp excess cost nbsp pfenex share commitment cost each case previously offset pursuant this section nbsp against royalty otherwise under this section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp within sixty nbsp following each quarterly period hospira shall pfenex amount payable pursuant this section nbsp wire transfer immediately available fund account designated pfenex style margin margin bottom text indent font size font family time roman align justify section nbsp report style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp with respect every quarterly period which hospira obligated make payment under section nbsp hospira shall furnish pfenex written report such quarterly period within sixty nbsp after such quarterly period showing reasonably specific detail style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp total gross sale product sold hospira affiliate calculation annual sale product during annual period which such quarterly period relates including amount deducted category from gross sale arrive sale style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp style font size vertical align style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp offset from royalty pursuant section style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp aggregate amount royalty payment paid under section nbsp hospira pfenex preceding quarterly period such annual period style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp exchange rate used determining payment amount dollar style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp with respect sale product invoiced dollar gross sale sale including adjustment deduction permitted made hereunder calculating same shall expressed dollar with respect sale product invoiced currency other than dollar gross sale sale including adjustment deduction permitted made hereunder calculating same shall expressed their dollar equivalent calculated using foreign currency exchange rate applicable currency used hospira ordinary course business publicly report financial result style margin margin bottom text indent font size font family time roman align justify section nbsp payment term payment hereunder shall made legal currency united state america payment portion thereof hereunder which paid when shall bear interest equal lesser rate equal thirty nbsp dollar libor rate effective date that payment published wall street journal internet edition money rate column date such payment plus additional percent maximum rate permitted applicable calculated number such payment delinquent this section nbsp shall limit other remedy available either party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center manufacture product sale marketing style margin margin bottom text indent font size font family time roman align justify section nbsp manufacturing effort hospira expense shall responsible control manufacturing product shall control procurement manufacture qualification component required manufacture product cost thereof including with respect product comparative clinical study connection therewith hospira elect manufacture fill package product itself engage third party which pfenex reasonable objection manufacture fill package product behalf designated product manufacturer style margin margin bottom text indent font size font family time roman align justify section nbsp tech transfer promptly following effective date pfenex hospira shall develop reasonably agree through executive steering committee plan which plan shall nbsp consistent form scope those technology transfer plan used pfenex connection with transfer process related both drug substance product third party prior signature date access which provided hospira prior signature date nbsp include information which information will formatted each case summarized that certain memorandum exchanged between party signature date referencing this agreement technical transfer plan activity conducted each party facilitate hospira designated product manufacturer establishment manufacturing capability drug substance product including transfer manufacturing strain provided that hospira designated product manufacturer shall agree writing nbsp maintain physical control over manufacturing strain time nbsp alter modify manufacturing strain manner such technical transfer plan shall provide among other thing that nbsp pfenex shall soon practicable deliver hospira designated product manufacturer pfenex know which clarity shall include equipment shall include manufacturing process drug substance product including analytical method with respect thereto manufacturing strain method protocol assessing quality releasing product possession pfenex current manufacturer drug substance product reasonably necessary hospira designated product manufacturer obtain required regulatory approval with respect manufacture product manufacture drug substance product nbsp each party shall make available personnel reasonably necessary performance respective obligation forth technical transfer plan technical transfer plan shall also include target completion date prior initiation comparative clinical study upon which target completion date pfenex activity obligation under technical transfer plan shall connection therewith pfenex hospira shall form joint technology transfer committee consisting equal number representative each pfenex hospira maximum number three nbsp representative each which shall responsible overseeing implementation technical transfer plan each party shall responsible cost expense incurred connection with performance obligation under technical transfer plan hospira shall responsible payment owed designated product manufacturer connection with technical transfer plan after completion activity assigned pfenex under technical transfer plan pfenex agrees reasonably style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify support hospira designated product manufacturer manufacture drug substance product hereunder hospira reasonable request hospira shall pfenex commercial hourly rate time spent personnel providing such support provided that pfenex shall provide style font size vertical align such support without charge notwithstanding foregoing hospira request pfenex cooperation with respect transfer manufacturing capability second person facility designated product manufacturer technical transfer plan established manufacturing capability hospira second designated product manufacturer hospira shall pfenex commercial hourly rate time spent personnel reimburse pfenex pocket cost expense incurred each case connection with pfenex cooperating hospira request clarity nbsp technical transfer plan shall include scale manufacturing process commercial scale validation manufacturing process validation quality control quality assessment release method protocol such purpose which hospira shall responsible nbsp pfenex shall have obligation manufacture supply hospira drug substance product style margin margin bottom text indent font size font family time roman align justify section nbsp manufacturing standard target product specification with respect product shall included development plan product style margin margin bottom text indent font size font family time roman align justify section nbsp product packaging labeling subject section nbsp hospira shall control content type packaging specification change supplement thereto product style margin margin bottom text indent font size font family time roman align justify section nbsp product documentation subject section nbsp hospira shall control content type procurement expense product documentation change supplement thereto product style margin margin bottom text indent font size font family time roman align justify section nbsp medical product complaint hospira shall have exclusive right control shall responsible management including preparation response with respect product complaint received from third party each product complaint related manufacturing packaging sale product connection therewith pfenex shall provide reasonable assistance requested hospira connection with preparation response such product complaint hospira cost expense style margin margin bottom text indent font size font family time roman align justify section nbsp product recall hospira shall sole expense have exclusive right control shall responsible recall product style margin margin bottom text indent font size font family time roman align justify section nbsp maintenance registration reporting hospira shall sole expense obtain maintain nbsp registration with respect product nbsp permit license registration granted regulatory agency with respect manufacture product hospira style margin margin bottom text indent font size font family time roman align justify section nbsp regulatory inspection except otherwise provided herein hospira shall responsible hospira sole expense handling responding other regulatory agency inspection with respect hospira manufacture product extent that hospira requires reasonable assistance pfenex order fulfill style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify obligation pursuant this section nbsp pfenex agrees reasonably cooperate with assist hospira hospira shall promptly reimburse pfenex pfenex pocket cost expense incurred connection with such cooperation requested hospira style margin margin bottom text indent font size font family time roman align justify section nbsp product pricing promotion agency contact style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp subject section nbsp hospira shall solely responsible hospira shall entitled control exercising discretion advertising marketing promotion including preparing distributing product documentation sale price pricing promotional marketing strategy term sale product hospira shall contact review discussion product documentation product with applicable governmental authority style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp during term hospira affiliate sell product third party whom also sell otherwise provides other product service which bundled product hospira affiliate shall shift allocate price discount otherwise weigh payment received such transaction combination transaction with purpose reducing disadvantaging sale product favor other product service consideration provided party affiliate order minimize payment owed hospira pfenex hereunder style margin margin bottom text indent font size font family time roman align justify section nbsp reporting adverse drug reaction style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp pharmaco vigilance agreement upon hospira request party shall enter into pharmaco vigilance agreement agreement reasonable customary term including nbsp providing detailed procedure regarding maintenance core safety information exchange safety data relating product including adverse drug response reporting worldwide basis providing that hospira will responsible establishing maintaining world wide database nbsp ensuring compliance with reporting requirement applicable regulatory authority including worldwide basis style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp adverse event reporting without limiting section nbsp pfenex shall within nbsp business report customer complaint adverse drug response english hospira designee such purpose event sufficient time allow hospira meet regulatory reporting requirement between party hospira shall responsible timely reporting adverse drug response complaint safety data relating product each applicable regulatory authority accordance with applicable pfenex will also inform hospira soon possible under circumstance compliance safety issue which pfenex becomes aware which have regulatory action with respect product pfenex will provide follow information perform analysis requested hospira support adverse event investigation style margin margin bottom text indent font size font family time roman align justify section nbsp sale marketing hospira shall directly indirectly through subsidiary commercially reasonable effort market promote sell distribute product such cost market promote sell distribute product shall paid hospira style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center product trademark intellectual property litigation style margin margin bottom text indent font size font family time roman align justify section nbsp nbsp nbsp nbsp nbsp product trademark style margin margin bottom text indent font size font family time roman align justify hospira shall have sole right select product name trademark trade dress style packaging labeling like used connection with commercialization product including special promotional advertising taglines each product specific trademark goodwill associated therewith application registration extension renewal other right relating thereto shall collectively referred product trademark hospira shall exclusive owner each product trademark hospira shall have sole right register renew expense each such product trademark country jurisdiction hospira choosing style margin margin bottom text indent font size font family time roman align justify extent permitted applicable hospira shall nbsp include phrase licensed from pfenex pfenex logo product documentation excluding product label packaging used each major market australia japan placed size style font size vertical align size hospira logo location reasonably determined hospira nbsp include phrase licensed from pfenex product label packaging used each major market australia japan placed size location reasonably determined hospira each case nbsp subject hospira obtaining necessary authorization therefor from applicable regulatory agency accordingly hospira shall commercially reasonable effort obtain such necessary authorization hospira shall have obligation remove modify phrase licensed from pfenex pfenex logo from product documentation including product label packaging once finalized subject foregoing pfenex hereby grant hospira affiliate third party distributor right pfenex name logo connection with hospira obligation pursuant this section nbsp pfenex logo goodwill associated therewith application registration extension renewal other right relating thereto shall sole property pfenex style margin margin bottom text indent font size font family time roman align justify section nbsp nbsp nbsp nbsp nbsp ownership invention between party right title interest invention other intellectual property including know made nbsp hospira personnel connection with this agreement pfenex personnel shall owned hospira hospira invention nbsp pfenex personnel connection with this agreement hospira personnel shall owned pfenex pfenex invention nbsp made jointly personnel hospira pfenex connection with this agreement shall jointly owned hospira pfenex joint invention provided that hospira hereby grant pfenex fully paid irrevocable exclusive license with right grant authorize sublicenses style font size vertical align notwithstanding foregoing pfenex shall only have right sublicense right under hospira manufacturing license third party nbsp solely with manufacturing production product implementing utilizing pfenex technology style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify pfenex expression technology nbsp solely from third party whom pfenex obtained control manufacturing development which substantially similar those licensed pfenex under hospira manufacturing license which licensed hospira hereunder except expressly provided this agreement understood that neither party shall have obligation account other profit obtain approval other party license assign otherwise exploit joint invention patent claiming same joint patent reason joint ownership thereof each party hereby waif right have under applicable jurisdiction require such approval accounting each party shall make such assignment hereby make such assignment necessary effect foregoing style margin margin bottom text indent font size font family time roman align justify section nbsp patent prosecution maintenance invention style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp hospira patent hospira shall have sole right sole discretion pursue prosecution maintenance patent claiming hospira invention style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp pfenex patent pfenex shall have sole right sole discretion pursue prosecution maintenance patent claiming pfenex invention style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp joint patent decision regarding prosecution maintenance joint patent shall made jointly pfenex hospira through oversight executive steering committee upon identification joint invention executive steering committee shall nbsp promptly discus such joint invention event hospira pfenex reasonably believe that such joint invention patentable select mutually acceptable firm conduct patentability assessment purpose determining whether joint invention patentable nbsp promptly review patentability assessment discus desirability filing joint patent nbsp make final decision with respect such filing including jurisdiction which such filing made soon practicable nbsp designate party purpose this section nbsp controlling party responsible prosecution maintenance such joint patent controlling party shall responsible using counsel selected executive steering committee implement decision executive steering committee regarding prosecution maintenance joint patent controlling party shall provide other party opportunity review comment upon text application within joint patent least nbsp business before filing with patent office controlling party shall provide other party with copy each patent application within joint patent filed together with notice filing date serial number controlling party shall keep other party advised status communication actual prospective filing submission regarding joint patent shall provide other party opportunity review comment such communication filing submission proposed sent patent office controlling party shall also notify executive steering committee grant joint patent controlling party shall cease prosecution maintenance modify claim joint patent country unless approved other party which approval shall unreasonably withheld third party cost incurred controlling party prosecution maintenance joint patent hereunder shall shared equally party accordingly other party shall controlling party share style font size vertical align such style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify third party cost disputed good faith within thirty nbsp receipt invoice therefor disputed amount shall paid within fifteen nbsp after resolution such dispute pursuant section controlling party shall provide other party with reasonable documentation connection with such invoice style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp disclosure each party acknowledges highly proprietary confidential nature unpublished patent application related information without limiting provision article viii agrees limit access such application information received from other party hereunder those need such access purpose this section nbsp limit thereof solely purpose this section nbsp without limiting foregoing disclosure made pursuant this section nbsp will structured manner provide reasonable access applicable information while limiting risk adversely affecting patentability subject matter disclosed style margin margin bottom text indent font size font family time roman align justify section nbsp intellectual property strategy style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp hospira shall hospira sole cost expense have sole control over creation implementation strategy related action including inter partes review declaratory judgment with respect patent third party each case with respect development manufacture launch including obtaining regulatory approval marketing commercialization sale product market including sole right determine nbsp when initiate such action with respect third party patent other than covered term section nbsp including example nullity invalidity case brought against third party patent specific development manufacture launch marketing commercialization sale product nbsp earliest date which product will manufactured imported used offered sale sold given country nbsp when change development manufacture product provided that modification manufacturing strain shall subject section nbsp order minimize effect third party intellectual property from development manufacture launch marketing commercialization sale product such institution circumvention strategy proactive seeking license from third party nbsp appropriate course action event third party commences action alleging that product development manufacture launch marketing commercialization sale product infringes intellectual property such third party other than covered term section nbsp including assuming controlling defense such action nbsp when settle compromise consent judgment with respect action with respect third party intellectual property provided that hospira shall required obtain pfenex prior written consent such consent unreasonably withheld conditioned delayed extent same would likely have material adverse effect pfenex affiliate their right strategy clarity nothing this section nbsp shall limit pfenex right with respect action related patent other intellectual property third party connection with development manufacture launch including obtaining regulatory approval marketing commercialization sale product other than product hereunder style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp pfenex shall provide cooperation assistance reasonably requested hospira connection with hospira implementation strategy including nbsp providing hospira prompt written notice action commenced third party against pfenex alleging that product business infringes intellectual property such third party nbsp providing hospira with document whether written electronic other form related product business including document related development product process used manufacture product nbsp identifying describing intellectual property that been incorporated into product pfenex nbsp allowing inspection whether court ordered otherwise facility owned operated controlled pfenex affiliate nbsp identifying providing witness will assist preparation evidence provide written evidence appear witness court assist other that hospira reasonably request extent that cooperation assistance requested result external cost being incurred pfenex then hospira shall responsible payment reasonably incurred external expense accordance with budget mutually agreed upon party style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp pfenex shall commence action with respect patent third party connection with development manufacture launch including obtaining regulatory approval marketing commercialization sale product take other action that violates conflict with hospira right under section nbsp without hospira prior written consent notwithstanding anything contrary this agreement pfenex commences such action contravention proceeding sentence strategy action such commencement shall constitute material breach pfenex this agreement without limiting hospira right with respect such material breach notwithstanding anything contained herein contrary pfenex shall accordance with instruction from hospira with respect such strategy action including instruction nbsp terminate such strategy action nbsp relinquish control such strategy action hospira whereupon pfenex will responsible cost incurred either party connection with such strategy action style margin margin bottom text indent font size font family time roman align justify section nbsp manufacturing process style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp event that third party commences action against either party such party affiliate alleging that manufacture product including pfenex technology manufacture product infringes intellectual property such third party manufacturing action party against whom such action commenced shall provide other party prompt written notice thereof following receipt such notice hospira shall have sole right determine appropriate course action including example assuming controlling defense such manufacturing action seeking license from such third party with respect such third party intellectual property hospira elect assume control over defense such manufacturing action where pfenex affiliate defendant then pfenex affiliate shall have right participate with counsel selection pfenex sole cost expense hospira shall subject section nbsp continue control defend pfenex affiliate until final judgment such manufacturing action style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp pfenex shall provide cooperation assistance reasonably requested hospira connection with manufacturing action including nbsp providing hospira with detailed response inquiry nbsp providing hospira with document whether written electronic other form related manufacturing process practice pfenex technology nbsp identifying describing intellectual property that been incorporated into process manufacture product pfenex nbsp identifying providing witness will assist preparation evidence provide written evidence appear witness court assist other that hospira reasonably request style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp hospira settle compromise consent judgment with respect manufacturing action without prior written consent pfenex fifteen nbsp business notice pfenex together with complete copy such proposed settlement compromise consent judgment such other document pfenex reasonably request provided that prior expiration such fifteen nbsp business period pfenex determines good faith advises hospira such determination writing that such settlement compromise consent judgment would likely have material adverse impact pfenex affiliate their right then hospira shall settle compromise consent judgment with respect such manufacturing action without prior written consent pfenex unreasonably withheld delayed conditioned style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp pfenex will responsible cost relating settlement compromise judgment arising from shall promptly reimburse hospira pocket cost expense connection with manufacturing action extent alleging that manufacturing strain constituent component thereof infringes intellectual property third party style margin margin bottom text indent font size font family time roman align justify section nbsp enforcement action style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp each party shall promptly give other party written notice each assertion notice actual suspected infringement misappropriation other violation third party pfenex technology excluding joint patent infringing activity that come such party affiliate attention well identity such third party evidence such infringing activity within such party affiliate custody control that such party affiliate reasonably able provide style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp pfenex shall have first right obligation pfenex sole cost expense take action response such infringing activity enter into permit settlement litigation other enforcement action collectively enforcement action provided that pfenex shall provide prompt written notice enforcement action hospira arising from development manufacture launch marketing commercialization sale competing product each competing product enforcement action permit hospira subject common interest agreement review comment such competing product enforcement action give reasonable consideration comment made hospira relation such competing product enforcement action required applicable extent pfenex have standing hospira shall permit shall take action reasonably necessary enable style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify enforcement action brought name including being joined necessary party pfenex sole cost expense pfenex settle compromise consent judgment with respect enforcement action without prior written consent hospira fifteen nbsp business notice hospira provided that prior expiration such fifteen nbsp business period hospira determines advises pfenex such determination writing that settlement compromise consent judgment with respect competing product enforcement action would likely have material adverse impact hospira affiliate their right reduce pfenex obligation under this agreement then pfenex shall settle compromise consent judgment with respect such competing product enforcement action without prior written consent hospira which consent shall unreasonably withheld delayed conditioned style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp pfenex institute competing product enforcement action against infringing activity involving pfenex technology within nbsp month from date assertion notice such shorter period reasonably necessary hospira take action necessary bring such competing product enforcement action pfenex provided notice hospira specifying that nbsp initiation such competing product enforcement action likely invalidate narrow claim pfenex patent nbsp such invalidation narrowing would likely have material adverse impact pfenex affiliate pfenex technology hospira shall have right obligation hospira sole cost expense bring competing product enforcement action provided that hospira shall provide prompt written notice such competing product enforcement action pfenex permit pfenex subject common interest agreement defined below review comment such competing product enforcement action give reasonable consideration comment made pfenex relation such competing product enforcement action such case required applicable extent hospira have standing pfenex shall permit shall take action reasonably necessary enable competing product enforcement action brought name including being joined necessary party hospira sole cost expense hospira enter into settlement consent judgment with respect such competing product enforcement action without prior written consent pfenex unreasonably withheld delayed conditioned style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp enforcement action instituted either pfenex hospira enforce pfenex technology provided herein above other party cooperating party shall reasonable request party initiating such enforcement action cooperate provide reasonable assistance party prosecuting enforcement action including nbsp providing prosecuting party with document whether written electronic other form related pfenex technology nbsp identifying describing intellectual property that been incorporated into pfenex technology cooperating party nbsp allowing inspection whether court ordered otherwise facility owned operated controlled cooperating party nbsp identifying providing witness will assist preparation evidence provide written evidence appear witness court assist other that prosecuting party reasonably request extent that cooperation assistance requested result external cost being incurred cooperating party then style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify requesting party shall responsible payment reasonably incurred external expense style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp each party shall promptly give other party written notice actual suspected infringement misappropriation other violation third party joint patent competing infringing activity that come such party affiliate attention executive steering committee shall nbsp promptly discus such competing infringing activity strategy enforcing joint patent nbsp designate with agreement party party responsible controlling such enforcement action with respect joint patent provided that unless otherwise agreed with respect such competing infringing activity hospira shall controlling party unless notifies pfenex within thirty nbsp notice applicable competing infringing activity such shorter period reasonably necessary hospira take action necessary bring such enforcement action party controlling such enforcement action enforcing party other party shall have right fund style font size vertical align pocket cost such enforcement action incurred accordingly other party shall notify enforcing party what portion such cost intends fund shall responsible such portion unless other party provides sixty nbsp prior written notice enforcing party indicating that intend bear further such cost style margin margin bottom text indent font size font family time roman align justify section nbsp reimbursement requirement extent that party would required pursuant this article reimburse other party cost expense incurred such other party such obligation shall subject submission such other party reasonable documentation with respect thereto extent that either party would entitled reimbursed otherwise have paid cost expense incurred such party such cost expense shall only reimbursed paid extent reasonably incurred such party third party cost disputed good faith within thirty nbsp receipt invoice therefor disputed amount shall paid within fifteen nbsp after resolution such dispute pursuant section style margin margin bottom text indent font size font family time roman align justify section nbsp recovered amount monetary damage court ordered third party cost settlement royalty other recovery received from third party resulting from arising relating competing product enforcement action enforcement action competing infringing activity shall distributed party rata basis based upon cost paid each party connection with such enforcement action style margin margin bottom text indent font size font family time roman align justify section nbsp common interest agreement party have entered that certain common interest agreement dated october nbsp common interest agreement term condition which shall continue govern conduct diligence sharing intellectual property related material each defined therein party acknowledge that term condition common interest agreement addition term condition hereof including section superceded hereby style margin margin bottom text indent font size font family time roman align justify section nbsp confidentiality action extent reasonably possible permitted applicable determined desirable hospira each party shall take style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify step necessary maintain confidential publish otherwise disclose existence substance strategy action commenced connection therewith including manufacturing action competing product enforcement action existence term settlement judgment award decree determination consent foregoing style margin margin bottom text indent font size font family time roman align justify section nbsp patent marking hospira shall mark cause marked product marketed sold hereunder with appropriate pfenex patent number indicia pfenex request extent permitted applicable those country which such notice impact recovery damage remedy available with respect infringement patent provided however that pfenex shall notify hospira nbsp year advance expiration such pfenex patent shall immediately notify hospira upon invalidation such pfenex patent style margin margin bottom text indent font size font family time roman align justify section nbsp article applicable article shall apply extent application would inconsistent with this article style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center executive steering committee style margin margin bottom text indent font size font family time roman align justify section nbsp nbsp nbsp nbsp nbsp formation purpose order oversee review coordinate activity party under this agreement pfenex hospira will form executive steering committee promptly after signature date executive steering committee whose initial member listed that certain memorandum exchanged between party signature date referencing this agreement executive steering committee shall accordance with procedure forth section nbsp nbsp review comment development manufacture commercialization product including development plan technical transfer plan clinical protocol conduct comparative clinical study nbsp consult with hospira regarding hospira plan seeking regulatory approval nbsp review approve modification amendment development plan nbsp review approve clinical protocol conduct comparative clinical study modification amendment thereto nbsp review approve technical transfer plan modification amendment thereto nbsp review comment strategy modification amendment thereto nbsp serve forum discussion matter relating development manufacture commercialization product nbsp establish estimated budget regulatory approval cost paid hospira each calendar year october nbsp style font size vertical align prior calendar year nbsp establish more working committee which shall include product development working committee manufacturing working committee other working group committee subcommittee established mutual consent pfenex hospira each working committee nbsp performing such other duty specifically assigned executive steering committee this agreement executive steering committee shall primary forum pfenex hospira communicate with another regarding plan progress development commercialization product well associated problem style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify section nbsp membership executive steering committee shall consist three nbsp employee hospira appointed hospira three nbsp individual appointed pfenex either pfenex hospira seek appoint individual listed that certain memorandum exchanged between party signature date referencing this agreement which shall include only initial member executive steering committee also other approved potential appointee pfenex hospira then appointing party shall notify appointing party appointing party shall have right comment each such appointee which such comment appointing party shall consider good faith unless otherwise agreed party executive steering committee each working committee shall have least nbsp representative with relevant decision making authority from each party such that such committee able effectuate decision within scope responsibility each member executive steering committee shall subject obligation disclosure confidential information forth article viii notwithstanding anything herein contrary requested hospira pfenex shall have right appoint member executive steering committee member hereunder individual that serving management committee member under pfenex collaboration with stride arcolab limited affiliate appointee joint steering committee thereunder style margin margin bottom text indent font size font family time roman align justify section nbsp meeting requirement executive steering committee shall meet quarterly basis frequently pfenex hospira mutually agree during term executive steering committee meet phone videoconference person each meeting shall held date agreed upon pfenex hospira notwithstanding foregoing meeting called time requested pfenex hospira prior written notice including corresponding agenda meeting sent pfenex hospira applicable least nbsp month advance provided that meeting required convened promptly pursuant this agreement pfenex hospira shall exercise commercially reasonable effort convene such meeting promptly practicable pfenex hospira agree that reasonable flexibility necessary therefore three nbsp different date shall proposed each meeting whenever possible meeting shall only effective least nbsp representative designated hospira nbsp representative designated pfenex present participating meeting style margin margin bottom text indent font size font family time roman align justify section nbsp decision making dispute resolution style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp executive steering committee shall have single chairperson will nbsp solicit agenda item from other executive steering committee member coordinate prepare agenda which shall include agenda item reasonably proposed executive steering committee member from other party provide agenda along with appropriate information such agenda reasonably advance extent possible meeting ensure orderly conduct executive steering committee meeting nbsp attend subject below each meeting executive steering committee nbsp prepare issue minute each meeting which shall accurately reflect discussion decision executive steering committee such meeting accordance with section nbsp such minute from each executive steering committee meeting shall finalized until executive steering committee member from other party have reviewed confirmed accuracy style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify such minute described section nbsp previously confirmed such matter shall first order business next executive steering committee meeting party appointing chairperson shall alternate between pfenex hospira every calendar year shall initially designated hospira event chairperson another representative executive steering committee from either party unable attend participate meeting executive steering committee party appointed such executive steering committee chairperson representative appoint substitute chairperson other representative that meeting decision executive steering committee working committee shall made consensus with each party having nbsp vote each party shall work good faith reach consensus matter general spirit cooperation event shall either party unreasonably withhold condition delay approval other decision executive steering committee working committee hereunder event working committee fails reach consensus with respect particular matter within authority then upon request either party such matter shall referred executive steering committee resolution style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp executive steering committee unable reach decision matter within authority including matter expressly required resolved executive steering committee pursuant this agreement after period nbsp business then either pfenex hospira provide written notice such dispute chief executive officer other party such matter shall resolved forth below chief executive officer their respective designees shall senior officer pfenex hospira shall member executive steering committee each pfenex hospira shall discus dispute person telephonically their good faith effort resolve dispute within thirty nbsp after submission such dispute such officer such dispute resolved chief executive officer their designees within thirty nbsp after submission such dispute such officer then style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp except chief executive officer pfenex shall have authority finally resolve such officer reasonable discretion exercised good faith matter related pfenex technology including prosecution maintenance pfenex invention enforcement thereof except matter that hospira right control pursuant section style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp general counsel hospira shall have authority finally resolve such officer reasonable discretion exercised good faith matter related strategy matter related hospira technology including prosecution maintenance hospira invention enforcement thereof style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp chief commercial officer hospira shall have authority finally resolve such officer reasonable discretion exercised good faith matter related commercialization product under this agreement style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp chief scientific officer hospira shall have authority finally resolve such officer reasonable discretion exercised good faith nbsp matter related clinical protocol conduct comparative clinical study nbsp matter style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify related regulatory affair including with respect communication regarding product nbsp subject section nbsp matter related development plan development program product data sheet style margin margin bottom text indent font size font family time roman align justify senior vice president operation hospira shall have authority finally resolve such officer reasonable discretion exercised good faith matter related commercial scale manufacturing product style margin margin bottom text indent font size font family time roman align justify chief executive officer hospira shall have authority finally resolve such officer reasonable discretion exercised good faith other matter previously addressed clause nbsp through nbsp above style margin margin bottom font size font family time roman align justify notwithstanding foregoing neither party shall have final decision making authority with respect matter described section nbsp section nbsp section style margin margin bottom text indent font size font family time roman align justify section nbsp meeting minute party shall reasonably cooperate finalize definitive minute executive steering committee later than thirty nbsp after meeting which minute pertain follows nbsp chairperson executive steering committee shall responsible preparing sending draft minute other party representative shall furnish such draft within nbsp such meeting nbsp other party representative shall have nbsp after receiving draft minute collect comment discus modification thereon nbsp within following nbsp dispute minute shall resolved between party final version minute shall issued party appointing chairperson which shall subject approval hospira pfenex signing dating minute unanimous approval executive steering committee meeting minute shall include list action decision determination approved executive steering committee list issue resolved addition minute shall forth place date where next meeting shall held style margin margin bottom text indent font size font family time roman align justify section nbsp expense each pfenex hospira shall responsible expense participation representative executive steering committee working committee including travel cost style margin margin bottom text indent font size font family time roman align justify section nbsp working committee each working committee shall nbsp comprised executive steering committee determines necessary fulfill responsibility being understood that particular working committee necessarily have same number representative from each party nbsp report into subordinate executive steering committee working committee shall only have authority expressly delegated such working committee executive steering committee each working committee shall keep executive steering committee regularly informed activity that tasked with overseeing otherwise carrying both through person written reporting reasonably necessary executive steering committee fulfill responsibility with respect thereto style margin margin bottom text indent font size font family time roman align justify section nbsp committee authority withdrawal style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp general notwithstanding creation executive steering committee working committee each party shall retain right power discretion granted hereunder committee shall delegated vested with right power discretion unless such delegation vesting expressly provided herein party expressly agree neither executive steering committee working committee shall have power nbsp amend modify waive compliance with this agreement nbsp determine whether party diligence other obligation under agreement nbsp determine whether breach this agreement occurred decision executive steering committee such working committee applicable shall contravention term condition this agreement understood agreed that issue formally decided executive steering committee working committee applicable only those specific issue that expressly provided this agreement decided executive steering committee such working committee applicable style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp withdrawal time after first anniversary effective date reason pfenex shall have right withdraw from participation executive steering committee working committee upon notice hospira referencing this section nbsp which notice shall effective immediately upon receipt thereafter hospira shall have sole authority resolve matter presented executive steering committee working committee from which pfenex withdrawn purpose clarification pfenex withdrawal from executive steering committee working committee shall affect other obligation responsibility pfenex forth this agreement style margin margin bottom text indent font size font family time roman align justify section nbsp responsibility each party shall responsible implementation operation activity hereunder which otherwise assigned responsibility under this agreement provided that such implementation inconsistent with express term this agreement decision executive steering committee working committee within scope authority specified herein applicable style margin margin bottom text indent font size font family time roman align justify section nbsp cooperation party that obligated cooperate with other party hereunder nbsp consider relevant factor including other then current obligation resource commitment when determining whether cooperation activity reasonable nbsp shall obligated obtain additional resource including hire personnel accomplish cooperation hereunder such party obligation cooperate particular activity shall alleviate other party obligation perform underlying activity style margin margin bottom font size font family time roman align center article viii style margin margin bottom font size font family time roman align center confidentiality nonsolicitation style margin margin bottom text indent font size font family time roman align justify section nbsp confidentiality each pfenex hospira acknowledges that course discussion negotiation performing obligation hereunder nbsp received receive information from other party nbsp other party disclose information data process that such other party wish protect from disclosure third party information described clause nbsp unless subject style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify confidentiality exception confidential information each party shall retain confidence confidential information other party except expressly provided herein shall confidential information such other party purpose other than purpose indicated herein connection with performance this agreement disclose such confidential information third party other than agent without written consent such other party confidential information shall include information that nbsp becomes public knowledge through fault receiving party agent nbsp made lawfully available receiving party other than under obligation confidentiality third party that knowledge receiving party under duty confidentiality disclosing party nbsp already receiving party possession time receipt from disclosing party such prior possession reasonably demonstrated competent evidence receiving party other than result disclosure third party that actual knowledge receiving party under duty confidentiality disclosing party with respect such information nbsp independently developed receiving party affiliate without reference confidential information other party such independent development reasonably demonstrated competent evidence prepared receiving party collectively confidentiality exception notwithstanding foregoing receiving party disclose confidential information other party nbsp extent required applicable provided however that legally permissible receiving party shall give disclosing party advance written notice promptly practicable permit seek protective order other similar order disclosing party sole cost with respect disclosure such confidential information thereafter receiving party shall disclose only minimum confidential information that advised counsel required disclosed order comply nbsp extent such disclosure reasonably necessary prosecution maintenance patent including application therefor accordance with section nbsp complying with term technology assignment agreement technology licensing agreement provided that pfenex shall provide hospira with prior written notice such disclosure including copy such disclosure prosecuting defending litigation conducting preclinical clinical trial obtaining maintaining regulatory approval including regulatory approval nbsp communication with consultant advisor including financial advisor lawyer accountant need know basis each case under appropriate confidentiality obligation substantially equivalent those this agreement provided that disclosing party shall responsible breach this section nbsp those person which discloses confidential information nbsp extent mutually agreed party style margin margin bottom text indent font size font family time roman align justify section nbsp agent each pfenex hospira shall limit disclosure other party confidential information only those their respective existing prospective affiliate director manager officer employee contractor collectively agent concerned with performance this agreement have legitimate need know such confidential information performance their duty bound written obligation disclosure least protective disclosing party confidential information term hereof each party shall responsible breach section nbsp agent consultant advisor including financial advisor lawyer accountant shall take reasonably necessary measure restrain agent consultant advisor style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify including financial advisor lawyer accountant from unauthorized disclosure confidential information style margin margin bottom text indent font size font family time roman align justify section nbsp restriction sharing information style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp notwithstanding anything contrary neither party shall obligated pursuant this agreement provide grant access information nbsp that reasonably good faith considers confidential information prevented from disclosing other party enforceable confidentiality agreement with third party that such party used commercially reasonable effort obtain consent such third party provide grant access such information other party nbsp disclosure which would adversely affect attorney client privilege between such party counsel nbsp disclosure which permitted pursuant applicable requirement governmental authority provided that each case where information provided access granted would otherwise required under this agreement such party shall inform other party reason provided granted description specific nature applicable information case clause such party shall request other party enter into common interest agreement with other party extent such agreement would permit disclosure such information without adversely affecting such attorney client privilege then disclose such information other party following effective date during term connection with entering into material agreement material amendment thereof with third party related business each party agrees commercially reasonable effort negotiate with such third party include provision such agreement such amendment sufficient allow other party receive relevant confidential information such third party style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp this agreement supersedes bilateral confidential disclosure agreement between party dated august nbsp prior agreement with respect information disclosed thereunder information exchanged between party under prior agreement shall deemed confidential information disclosing party shall subject term section style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp addition obligation regarding hospira confidential information notwithstanding anything contrary herein pfenex shall disclose confidential information hospira with respect development plan regulatory material other confidential information hospira reasonably requested hospira from time time with employee independent contractor consultant pfenex that working have time worked strategy preparation prosecution maintenance regulatory filing pegfilgrastim application therefor each case pursuant pfenex collaboration with stride arcolab limited affiliate extent such information shared with employee independent contractor consultant pfenex such individual shall prohibited from thereafter working strategy preparation prosecution maintenance regulatory filing pegfilgrastim application therefor each case pursuant pfenex collaboration with stride arcolab limited affiliate style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify section nbsp nbsp nbsp nbsp nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp pfenex permitted assignee shall deliver hospira prior date this agreement promptly upon request hospira accurate complete originally signed form successor other applicable form prescribed internal revenue service addition pfenex agrees that from time time after date hereof when lapse time change circumstance occurs other reason render prior form provided hereunder obsolete inaccurate respect pfenex permitted assignee shall promptly deliver hospira accurate complete originally signed form successor other applicable form prescribed internal revenue service style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp party agree that federal income purpose they will treat transaction under this agreement unless otherwise required applicable collaboration agreement that constitute partnership joint venture agree take cause person take position return course audit examination other proceeding inconsistent with such treatment unless otherwise required applicable except upon final determination applicable taxing authority style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp payment account obligation party under this agreement shall made without deduction withholding except required applicable applicable determined good faith discretion applicable withholding party requires deduction withholding from such payment party then applicable party shall entitled make such deduction withholding amount deducted withheld shall deemed paid other party that entitled payment subject withholding shall timely full amount deducted withheld relevant governmental authority accordance with applicable such indemnified then payable applicable assignee shall increased necessary that after such deduction withholding been made including such deduction withholding applicable additional payable under this section applicable recipient receives amount equal would have received such deduction withholding been made upon request other party such withholding party shall deliver other party that entitled payment subject withholding original certified copy receipt issued such governmental authority evidencing such payment copy return reporting such payment other evidence such payment reasonably satisfactory other party style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp assignee shall indemnify assigning party within nbsp after demand therefor full amount indemnified including indemnified imposed asserted attributable amount payable under this section payable paid such assigning party required withheld deducted from payment such assigning party reasonable expense arising therefrom with respect thereto whether such indemnified were correctly legally imposed asserted relevant governmental authority notwithstanding anything contrary party affiliate thereof indemnified party actually receives refund obtains actually utilizes credit reduce liability from governmental authority style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify portion indemnified which indemnified under this section nbsp other party indemnifying party then indemnified party shall promptly reimburse indemnifying party amount such refund credit only extent payment made under this section nbsp with respect giving rise such refund credit pocket expense including such indemnified party without interest other than interest paid relevant governmental authority with respect such refund credit provided however that such indemnifying party upon request such indemnified party shall repay such indemnified party amount refund credit paid over pursuant this sentence event that such indemnified party required repay such refund credit such governmental authority upon request indemnifying party indemnified party shall commercially reasonable effort obtain available refund credit with respect such indemnified style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp transfer documentary sale excise custom charge duty valorem value added stamp registration recording property other such similar other than avoidance doubt assessed against income conveyance recording charge other charge including penalty interest lawfully assessed charged connection with transaction contemplated under this agreement collectively transfer shall paid borne pfenex hospira when party responsible under such applicable paying such transfer shall expense file necessary return other documentation with respect such transfer required applicable party will will cause their affiliate join execution such return other documentation style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp party acknowledge agree that under current amount contemplated payable under this agreement hospira pfenex pfenex hospira pursuant this agreement subject withholding deduction extent that result change bahamas payment pfenex pursuant this agreement becomes subject bahamas withholding hospira shall indemnify pfenex within nbsp after demand therefor full amount withholding imposed bahamas such payment including bahamas withholding imposed amount payable under this section nbsp notwithstanding anything contrary pfenex affiliate thereof actually obtains refund credit from governmental authority portion which indemnified under this section nbsp hospira pfenex shall promptly reimburse hospira amount such refund credit upon request hospira pfenex shall commercially reasonable effort obtain available refund credit with respect such style margin margin bottom text indent font size font family time roman align justify section nbsp nbsp nbsp nbsp nbsp nonsolicitation each party purpose this section nbsp soliciting party agrees that during term such soliciting party will solicit employment consultancy employ engage consultant solicit termination employment consultancy with other party solicitation action individual that time such solicitation action nbsp officer employee other party consultant that devoting substantial majority such individual time business other party nbsp actively involved other party performance obligation hereunder provided style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify however that foregoing shall prohibit nbsp advertisement general solicitation hiring engagement consultant result thereof employment consultancy specifically directed such individual nbsp hiring engagement consultant such individual initiate employment consultancy discussion with such soliciting party provided that such initial discussion encouraged solicited such soliciting party nbsp solicitation action with respect individual following cessation such individual employment with service consultant that devoting substantial majority such person time business other party without solicitation encouragement such soliciting party style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center representation warranty covenant style margin margin bottom text indent font size font family time roman align justify section nbsp representation warranty pfenex pfenex hereby represents warrant hospira signature date follows style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp organization good standing pfenex duly incorporated validly existing good standing under delaware with requisite power authority required conduct business presently conducted style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp authority pfenex requisite power authority execute deliver this agreement perform obligation hereunder execution delivery pfenex this agreement performance pfenex obligation hereunder have been duly authorized requisite corporate similar action pfenex other action part pfenex shareholder board director necessary authorize execution delivery performance pfenex this agreement style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp valid binding agreement this agreement been duly executed delivered pfenex constitutes legal valid binding obligation pfenex enforceable against pfenex accordance with term except extent that enforceability thereof limited nbsp applicable bankruptcy insolvency fraudulent conveyance reorganization moratorium similar from time time effect affecting generally enforcement creditor right nbsp general principle equity style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp contravention execution delivery this agreement pfenex performance pfenex obligation hereunder including grant license pursuant article will nbsp violate provision organizational document pfenex nbsp conflict with violate applicable applicable pfenex asset property nbsp require permit authorization consent approval exemption other action notice filing with entity governmental authority other than expressly contemplated hereby nbsp violate conflict with result material breach constitute with without notice lapse time both material default under event which would give rise right notice modification acceleration payment cancellation termination under manner release party thereto from obligation under permit contract which pfenex party which property asset bound each case that necessary pfenex performance obligation style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify grant right hospira hereunder nbsp result creation imposition lien part property asset pfenex style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp commission pfenex under obligation commission similar connection with transaction contemplated this agreement which hospira shall made responsible shall become obligated reason style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp litigation there proceeding against pfenex affiliate that been brought pfenex affiliate which pending pfenex knowledge threatened writing pfenex knowledge there investigation pfenex affiliate pending before governmental authority each case nbsp that would reasonably expected prevent consummation transaction contemplated this agreement nbsp that would reasonably expected materially adversely affect development program product conduct business nbsp that would reasonably expected materially adversely affect reimbursement product under program funded governmental authority style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp regulatory matter compliance with pfenex affiliate have been time compliance respect with applicable that were applicable conduct business ownership product except where compliance with applicable would reasonably expected have individually aggregate material adverse effect product conduct business pfenex ability perform obligation hereunder governmental authority notified pfenex affiliate pfenex knowledge subcontractor writing that activity conduct business violation applicable subject proceeding investigation except where violation applicable proceeding investigation would reasonably expected have individually aggregate material adverse effect product conduct business pfenex ability perform obligation hereunder style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp competing product neither pfenex affiliate currently owns license competing product stage development commercialization have currently ongoing program develop acquire such competing product style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp pfenex technology style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp pfenex control pfenex patent listed that certain memorandum exchanged between party signature date referencing this agreement pfenex granted right third party under pfenex technology that conflict with right granted hospira hereunder none pfenex technology pfenex knowledge been subject pending proceeding with respect inventorship challenge interference reissue reexamination inter partes review post grant review supplemental review invalidation opposition cancellation abandonment order decree governmental authority restricting such pfenex technology connection with product pfenex knowledge none pfenex style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify technology been subject threatened proceeding type described immediately prior sentence style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp neither pfenex pfenex affiliate received written notice from third party claiming that practice pfenex technology conduct business development making using sale offer sale import product infringes patent claim third party misappropriates make unauthorized intellectual property right third party style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp pfenex knowledge third party infringing misappropriating making unauthorized pfenex technology there proceeding investigation contemplation proceeding pfenex pending threatened against third party related pfenex technology style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp none pfenex technology subject outstanding decree order judgment stipulation governmental authority against pfenex affiliate pfenex knowledge other person restricting manner conduct business development making sale offer sale import product style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp other than technology licensing agreement technology assignment agreement there contract pursuant which pfenex license otherwise right under patent intellectual property right third party that material business product pfenex technology pfenex licensed otherwise granted right third party under pfenex technology with respect product reference product style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp pfenex owns received license otherwise sufficient right with respect pfenex technology necessary pfenex comply with term this agreement style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp manufacturing process pfenex knowledge manufacturing strain constituent component thereof used behalf pfenex signature date infringe intellectual property right third party style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp debarment neither pfenex affiliate subcontractor employee agent ever been currently subject debarment proceeding that could lead that party becoming applicable debarred entity debarred individual style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp adverse finding pfenex knowledge there event discovery fact development change circumstance which individually aggregate could reasonably expected have material adverse effect only taking into consideration information reasonably available signature date development plan ability obtain regulatory approval manufacture commercialize promote import market offer sale sell distribute product during term pfenex disclosed hospira material information known pfenex with respect product style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify development thereof only taking into consideration information reasonably available signature date style margin margin bottom text indent font size font family time roman align justify section nbsp representation warranty hospira hospira hereby represents warrant pfenex signature date follows style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp organization good standing hospira duly incorporated validly existing good standing under delaware with requisite power authority required conduct business presently conducted style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp authority hospira requisite corporate power authority execute deliver this agreement perform obligation hereunder execution delivery hospira this agreement performance hospira obligation hereunder have been duly authorized requisite corporate action hospira other action part hospira stockholder board director necessary authorize execution delivery performance hospira this agreement style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp valid binding agreement this agreement been duly executed delivered hospira constitutes legal valid binding obligation hospira enforceable against hospira accordance with term except extent that enforceability thereof limited nbsp applicable bankruptcy insolvency fraudulent conveyance reorganization moratorium similar from time time effect affecting generally enforcement creditor right nbsp general principle equity style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp contravention execution delivery this agreement hospira performance hospira obligation hereunder will nbsp violate provision organizational document hospira nbsp conflict with violate applicable applicable hospira asset property nbsp require permit authorization consent approval exemption other action notice filing with entity governmental authority other than expressly contemplated hereby nbsp violate conflict with result material breach constitute with without notice lapse time both material default under event which would give rise right notice modification acceleration payment cancellation termination under manner release party thereto from obligation under permit contract which hospira party which property asset bound each case that necessary hospira performance obligation grant right pfenex hereunder nbsp result creation imposition lien part property asset hospira style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp commission hospira under obligation commission similar connection with transaction contemplated this agreement which pfenex shall made responsible shall become obligated reason style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp litigation there proceeding against hospira affiliate that been brought hospira affiliate which pending hospira knowledge threatened writing hospira knowledge there style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify investigation hospira affiliate pending before governmental authority each case nbsp that would reasonably expected prevent consummation transaction contemplated this agreement nbsp that would reasonably expected materially adversely affect development program product conduct business nbsp that would reasonably expected materially adversely affect reimbursement product under program funded governmental authority style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp debarment hospira represents warrant that neither affiliate subcontractor employee agent ever been currently subject debarment proceeding that could lead that party becoming applicable debarred entity debarred individual style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp competing product neither hospira affiliate currently owns license competing product stage development commercialization have currently ongoing program develop acquire such competing product style margin margin bottom text indent font size font family time roman align justify section nbsp debarment covenant style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp pfenex during term pfenex affiliate subcontractor employee agent becomes subject investigation debarment proceeding that could lead pfenex such affiliate subcontractor employee agent applicable becoming debarred entity debarred individual pfenex shall immediately notify hospira such occurrence materially adversely affect pfenex ability perform obligation hereunder hospira ability develop obtain regulatory approval manufacture commercialize promote market offer sale sell distribute product then such occurrence shall deemed material breach this agreement hospira shall have right terminate this agreement pursuant section nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp hospira during term hospira affiliate subcontractor employee agent becomes subject investigation debarment proceeding that could lead hospira such affiliate subcontractor employee agent applicable becoming debarred entity debarred individual hospira shall immediately notify pfenex such occurrence materially adversely affect hospira ability perform obligation hereunder then such occurrence shall deemed material breach this agreement pfenex shall have right terminate this agreement pursuant section nbsp style margin margin bottom text indent font size font family time roman align justify section nbsp disclaimer warranty except forth section section pfenex hospira expressly disclaim warranty express implied statutory otherwise with respect subject matter this agreement including product pfenex technology hospira technology including warranty merchantability noninfringement fitness particular purpose style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify section nbsp public announcement neither party their respective affiliate shall make public announcement regarding this agreement disclose term condition this agreement other agreement contemplated hereby third party without prior written consent other party unreasonably withheld delayed conditioned except nbsp advisor including consultant financial advisor attorney accountant need know basis each case under circumstance that reasonably protect confidentiality thereof nbsp extent such disclosure required applicable including security nbsp potential acquirer majority asset such party related this agreement equity such party connection with negotiation definitive agreement long disclosing party provides other party with prior written notice such disclosure party shall required disclose other person such negotiation term proposed transaction nbsp those term condition specifically designated disclosure that certain memorandum exchanged between party signature date referencing this agreement nbsp otherwise mutually agreed party which agreement shall unreasonably withheld conditioned delayed shall take into consideration need accuracy compliance with nbsp regulatory guidance document nbsp market requirement york stock exchange such other recognized exchange which security party affiliate listed notwithstanding foregoing nbsp without prior written consent other party pfenex hospira nbsp file with security exchange commission current report form describing this agreement transaction contemplated hereby file copy this agreement with exhibit such current report form subsequent periodic report provided that party shall consult with each other minimize necessary disclosure shall seek confidential treatment such portion this agreement term condition thereof agreed upon party permitted under applicable nbsp party agree issue joint press release announcing execution this agreement which attached hereto exhibit thereafter pfenex hospira each disclose third party information contained such current report form such press release without need further approval other party style margin margin bottom text indent font size font family time roman align justify section nbsp insurance style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp pfenex insurance pfenex shall procure maintain expense duration this agreement five nbsp year thereafter written claim made occurrence reported form type insurance specified below with carrier rated better with best similar rating agency style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp worker compensation insurance accordance with applicable which shall include waiver subrogation favor hospira style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp employer liability insurance with limit liability amount than style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp commercial general liability insurance including premise operation product completed operation blanket contractual liability personal injury style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify advertising injury including fire legal liability bodily injury property damage amount than occurrence aggregate style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp commercial automobile liability insurance owned hired owned motor vehicle with combined single limit amount than occurrence style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp excess liability insurance including product clinical trial liability with combined single limit amount than occurrence aggregate provided that such amount shall increased from after first commercial sale product hospira style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp commercial crime fidelity bond insurance amount than occurrence aggregate including endorsement third party liability without requirement conviction style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp cargo transit insurance covering risk physical loss damage cargo handled pfenex full replacement cost style margin margin bottom text indent font size font family time roman align justify hospira affiliate director officer employee agent shall additional insured with respect commercial general liability commercial automobile liability excess liability policy described this section nbsp prior commencement service annually thereafter pfenex shall furnish hospira with certificate insurance evidencing insurance coverage described this section nbsp case cancellation renewal material change such coverage pfenex shall promptly notify hospira provide hospira with certificate insurance evidencing that pfenex obtained policy insurance that meet requirement this section nbsp pfenex agrees that insurance shall primary noncontributory from other valid collectible insurance maintained hospira style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp hospira insurance hospira shall procure maintain expense duration this agreement five nbsp year thereafter written claim made occurrence reported form type insurance specified below with carrier rated better with best similar rating agency style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp worker compensation insurance accordance with applicable which shall include waiver subrogation favor pfenex style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp employer liability insurance with limit liability amount than style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp commercial general liability insurance including premise operation product completed operation blanket contractual liability personal injury advertising injury including fire legal liability bodily injury property damage amount than occurrence aggregate style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp commercial automobile liability insurance owned hired owned motor vehicle with combined single limit amount than occurrence style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp excess liability insurance including product liability with combined single limit amount than occurrence aggregate style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp commercial crime fidelity bond insurance amount than occurrence aggregate including endorsement third party liability without requirement conviction style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp cargo transit insurance covering risk physical loss damage cargo handled hospira full replacement cost style margin margin bottom text indent font size font family time roman align justify pfenex affiliate director officer employee agent shall additional insured with respect commercial general liability commercial automobile liability excess liability policy described this section nbsp prior commencement service annually thereafter hospira shall furnish pfenex with certificate insurance evidencing insurance coverage described this section nbsp case cancellation renewal material change such coverage hospira shall promptly notify pfenex provide pfenex with certificate insurance evidencing that hospira obtained policy insurance that meet requirement this section nbsp hospira agrees that insurance shall primary noncontributory from other valid collectible insurance maintained pfenex style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center term termination dispute style margin margin bottom text indent font size font family time roman align justify section nbsp term except provision article xiii section which shall effective from signature date this agreement shall become effective effective date unless this agreement terminated accordance with section nbsp shall continue full force effect until twenty nbsp year anniversary date first commercial sale product hospira initial term upon expiration initial term subsequent term this agreement shall automatically renew successive nbsp year period each subsequent term initial term together with subsequent term shall referred herein term unless hospira provides pfenex with written notice renewal least nbsp month prior date which term would otherwise automatically renew additional nbsp year period style margin margin bottom text indent font size font family time roman align justify section nbsp termination style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp pfenex terminate this agreement entirety style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp upon sixty nbsp prior written notice hospira style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom margin left text indent font size font family time roman align justify nbsp nbsp nbsp nbsp final determination been made pursuant dispute resolution procedure forth section that hospira committed material breach this agreement with specific nature such breach being identified such notice hospira fails cure such breach within such sixty nbsp period provided that hospira material breach been cured within sixty nbsp hospira shall allowed additional time reasonably necessary cure such breach long hospira provided pfenex within such sixty nbsp plan cure such breach soon practicable under circumstance diligently pursues cure completion accordance with such plan style margin margin bottom margin left text indent font size font family time roman align justify nbsp nbsp nbsp nbsp neutral notified party that material breach cured curable that right termination permitted pursuant this section nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp immediately upon notice hospira following case insolvency appointment receiver court competent jurisdiction with respect asset hospira assignment benefit creditor asset hospira entry order relief under title united state code against hospira style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp hospira terminate this agreement entirety style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp upon sixty nbsp prior written notice pfenex style margin margin bottom margin left text indent font size font family time roman align justify nbsp nbsp nbsp nbsp final determination been made pursuant dispute resolution procedure forth section that pfenex committed material breach this agreement with specific nature such breach being identified such notice pfenex fails cure such breach within such sixty nbsp period provided that pfenex material breach been cured within sixty nbsp pfenex shall allowed additional time reasonably necessary cure such breach long pfenex provided hospira within such sixty nbsp plan cure such breach soon practicable under circumstance diligently pursues cure completion accordance with such plan style margin margin bottom margin left text indent font size font family time roman align justify nbsp nbsp nbsp nbsp neutral notified party that material breach cured curable that right termination permitted pursuant this section style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp immediately upon notice pfenex following case insolvency appointment receiver court competent jurisdiction with respect asset pfenex assignment benefit creditor asset pfenex entry order relief under title united state code against pfenex style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp upon sixty nbsp prior written notice pfenex style margin margin bottom margin left text indent font size font family time roman align justify nbsp nbsp nbsp nbsp reference product longer being marketed commercialized sold major market result patient safety issue style margin margin bottom margin left text indent font size font family time roman align justify nbsp nbsp nbsp nbsp product experienced failure meet clinical endpoint style margin margin bottom margin left text indent font size font family time roman align justify nbsp nbsp nbsp nbsp data safety monitoring board notified hospira that product safe recommends that comparative clinical study stopped style margin margin bottom margin left text indent font size font family time roman align justify nbsp nbsp nbsp nbsp hospira receipt complete response letter pursuant similar successor correspondence from equivalent decision regulatory agency another country regarding product such that hospira chief scientific officer determines good faith that hospira unlikely receive receipt regulatory approval more major market with respect product style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp clearance date occurred before hundred eighty nbsp after signature date then either party shall have right terminate this agreement entirety upon notice other party referencing this section nbsp provided that such delay breach such terminating party clarity understood that clearance date occurs prior termination agreement pursuant this section nbsp this agreement shall become effective entirety without further action either party style margin margin bottom text indent font size font family time roman align justify section nbsp general effect expiration termination upon termination this agreement expiration term article definition section nbsp period forth therein article product trademark intellectual property litigation article viii confidentiality nonsolicitation article representation warranty covenant with respect breach thereof signature date this article term termination article indemnification liability limit article xiii miscellaneous shall survive expiration termination this agreement notwithstanding anything contained this agreement contrary event shall termination expiration this agreement affect party obligation amount owed other party time such termination expiration release either party other obligation liability which time such expiration termination already accrued other party which attributable period prior such expiration termination except otherwise expressly provided this article awarded under ruling neutral right obligation party under this agreement shall terminate upon expiration termination this agreement reason style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify section nbsp additional effect expiration certain hospira termination this agreement expires term terminated hospira pursuant section nbsp then style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp transition assistance applicable during inventory sell down period nbsp hospira agrees cooperate with pfenex designee facilitate transition development manufacture commercialization product pfenex designee after expiration termination this agreement nbsp upon request pfenex hospira shall transfer pfenex some quantity unlabeled product affiliate control requested pfenex within thirty nbsp hospira receipt such request provided however that pfenex shall hospira total cost that hospira actually incurred manufacture otherwise acquire quantity provided pfenex plus style font size vertical align such cost nbsp upon pfenex request executive steering committee shall promptly event more than thirty nbsp after such request meet establish transition plan implement transition product pfenex designee accordingly hospira shall take action reasonably necessary cooperate with pfenex designee facilitate smooth orderly prompt transition product that pfenex designee fully enabled control over ongoing development manufacture commercialization product style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp regulatory material promptly following inventory sell down period style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp hospira shall promptly assign transfer pfenex regulatory material product that held controlled under authority hospira affiliate shall take such action execute such other instrument assignment document necessary effect transfer right under regulatory material pfenex pfenex shall assume obligation including pharmacovigilance obligation under applicable with regard such regulatory material style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp hospira shall cause each affiliate transfer such regulatory material pfenex this agreement terminates expires style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp applicable prevents delay transfer ownership possession regulatory material pfenex hospira shall grant hereby grant pfenex exclusive except hospira extent necessary comply with applicable irrevocable right access reference such regulatory material product shall cooperate fully make benefit such regulatory material available pfenex designee style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp hospira shall provide pfenex copy such regulatory material style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp pfenex shall free disclose such regulatory material other item connection with exercise right license under this section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp inventory sale period inventory sell down period hospira affiliate continue distribute sell labeled product remaining hospira inventory time expiration termination this agreement pfenex hereby grant hospira worldwide exclusive license sell distribute such remaining labeled product inventory connection therewith clarity product sold hospira affiliate pursuant this section nbsp shall subject payment under article with respect thereto style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp osts expense except expressly provided herein each party shall perform obligation under this section nbsp cost style margin margin bottom text indent font size font family time roman align justify section nbsp additional effect upon termination expiration style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp termination this agreement terminated prior expiration term then pfenex shall hospira unpaid unreimbursed comparative clinical study cost regulatory approval cost commitment cost each case only extent portion that pfenex owes hospira pursuant term article within payable each full quarterly period after effective date such termination provided that event this agreement terminated after prior pfenex shall hospira such unpaid unreimbursed amount later than later nbsp nbsp after such termination provided further that event this agreement terminated after pfenex shall hospira such unpaid unreimbursed amount within after such termination style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp expiration this agreement expires term then pfenex shall hospira unpaid unreimbursed comparative clinical study cost regulatory approval cost commitment cost each case only extent portion that pfenex owes hospira pursuant term article within thirty nbsp following such expiration style margin margin bottom text indent font size font family time roman align justify section nbsp dispute style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp event that dispute difference question arises pertaining matter which subject this agreement otherwise resolved accordance with section nbsp dispute prior initiation arbitration described section nbsp dispute shall submitted chief executive officer their respective designees hospira pfenex shall their good faith effort resolve dispute within fourteen nbsp after notice provided pursuant section nbsp such dispute resolved chief executive officer their designees within fourteen nbsp after submission such dispute such officer then dispute shall resolved accordance with arbitration procedure forth section nbsp clarity dispute include nbsp disagreement regarding interpretation this agreement nbsp breach alleged breach party obligation under this agreement associated remedy damage party event breach agreement other party structure payment such style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify damage nbsp appropriate remedy breach this agreement party including upon termination this agreement style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp party shall only permitted exercise right terminate this agreement pursuant section nbsp section nbsp applicable nbsp neutral determined material breach occurred nbsp breaching party failed cure such material breach provided section nbsp section nbsp nbsp neutral determined that monetary remedial measure would adequately compensate such party other party uncured material breach style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp party hereby acknowledge that right termination hospira result material breach this agreement pfenex will provide adequate remedy hospira case material breach this agreement pfenex neutral shall have option obligated consider part hospira remedy assuming monetary remedial measure would adequately compensate hospira style font size vertical align style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp similarly party hereby acknowledge that right termination pfenex result material breach this agreement hospira will provide adequate remedy pfenex case material breach this agreement hospira neutral shall have option obligated consider part pfenex remedy assuming monetary remedial measure would adequately compensate pfenex style font size vertical align style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center indemnification liability limit style margin margin bottom text indent font size font family time roman align justify section nbsp indemnification pfenex pfenex shall indemnify defend hold harmless collectively indemnify hospira affiliate their respective director officer employee agent hospira indemnitees from against loss damage liability penalty cost expense including reasonable attorney court cost collectively loss resulting from suit claim action demand each case brought third party each third party claim against hospira indemnitee arising nbsp breach pfenex obligation representation warranty hereunder nbsp gross negligence recklessness willful misconduct pfenex affiliate their respective officer director employee agent representative connection with performance this agreement nbsp violation pfenex affiliate their respective officer director employee agent representative applicable applicable performance pfenex obligation under this agreement pfenex obligation indemnify hospira indemnitees pursuant style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify this section nbsp shall apply extent such loss attributable cause event described clause nbsp nbsp section style margin margin bottom text indent font size font family time roman align justify section nbsp indemnification hospira hospira shall indemnify pfenex affiliate their respective director officer employee agent representative pfenex indemnitees from against loss resulting from third party claim against pfenex indemnitee arising nbsp breach hospira obligation representation warranty hereunder nbsp gross negligence recklessness willful misconduct hospira affiliate their respective officer director employee agent representative connection with performance this agreement nbsp violation hospira affiliate their respective officer director employee agent representative applicable applicable performance hospira obligation under this agreement nbsp development manufacture handling storage import transport promotion marketing advertising distribution sale product hospira employee agent affiliate hospira obligation indemnify pfenex indemnitees pursuant this section nbsp shall apply extent such loss attributable cause event described clause nbsp nbsp section nbsp style margin margin bottom text indent font size font family time roman align justify section nbsp indemnification procedure style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp party seeking indemnification under this article indemnified party agrees give prompt written notice indemnification notice party against whom indemnity sought indemnifying party assertion third party claim commencement proceeding respect which indemnity sought under this article provided that failure indemnified party promptly notify indemnifying party timely basis will relieve indemnifying party liability that have indemnified party unless extent indemnifying party demonstrates that materially prejudiced indemnified party failure give timely notice style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp indemnifying party object claim claim made indemnification notice written objection indemnification objection prior expiration twenty nbsp business from indemnifying party receipt indemnification notice indemnifying party shall deemed object information contained within indemnification notice nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp indemnifying party delivers indemnification objection within such twenty nbsp business period indemnifying party indemnified party shall attempt good faith resolve dispute twenty nbsp business after indemnifying party receipt such indemnification objection resolution reached dispute shall resolved accordance with provision section style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp indemnifying party elect assume control defense third party claim indemnifying party expense shall consult with indemnified party with respect thereto including employment counsel reasonably satisfactory indemnified party provided however that indemnifying party shall style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify have right assume control such defense claim that indemnifying party seek assume control nbsp seek material monetary relief nbsp involves criminal quasi criminal allegation indemnifying party permitted assume control defense third party claim elect indemnified party shall have right employ counsel separate from counsel employed indemnifying party such action participate defense thereof expense such counsel employed indemnified party shall expense indemnified party unless nbsp indemnifying party specifically agreed writing otherwise nbsp indemnified party been advised outside counsel that reasonable likelihood exists material legal conflict interest between indemnifying party indemnified party nbsp indemnifying party failed assume defense employ counsel which case expense indemnified party counsel shall paid indemnifying party indemnifying party otherwise obligation indemnify indemnified party related third party claim indemnifying party assumed defense third party claim accordance with term hereof indemnifying party enter into settlement consent judgment without prior written consent indemnified party unless nbsp such settlement judgment involves monetary damage only which will paid without limitation indemnifying party admission fault culpability behalf indemnified party nbsp term settlement judgment that person person asserting such claim unconditionally irrevocably release indemnified party from liability with respect such claim otherwise consent indemnified party shall required order enter into settlement consent entry judgment with respect claim which consent shall unreasonably withhold delayed conditioned indemnifying party assume controlling defense third party claim reason then indemnified party retain counsel choosing expense indemnifying party assume control defense such third party claim indemnifying party shall have right employ counsel separate from counsel employed indemnified party such action participate defense thereof expense such counsel employed indemnifying party shall expense indemnifying party indemnifying party shall have obligation with respect loss resulting from indemnified party admission settlement other communication without prior written consent indemnifying party which shall unreasonably withheld delayed conditioned style margin margin bottom text indent font size font family time roman align justify section nbsp limitation liability except arising failure party amount owed hereunder arising result fraud willful misconduct omission party arising from breach party confidentiality obligation section obligation under section except with respect obligation indemnify party under section section neither party their respective affiliate director member officer employee subcontractor agent shall have under legal theory including contract negligence tort liability liability other party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify consequential special indirect incidental punitive damage arising related breach this agreement style margin margin bottom text indent font size font family time roman align justify section nbsp unavailability indemnification indemnification provided this article held court competent jurisdiction unavailable indemnified party with respect loss then indemnifying party shall lieu indemnifying such indemnified party hereunder contribute amount paid payable such indemnified party result such loss such proportion appropriate reflect relative fault relative benefit enjoyed indemnifying party hand relative fault relative benefit enjoyed indemnified party other hand connection with action omission that resulted such loss well other relevant equitable consideration style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center antitrust filing style margin margin bottom text indent font size font family time roman align justify section nbsp general with respect reporting waiting requirement under party agree follows style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp filing each hospira pfenex shall file soon practicable later than nbsp business after signature date with notification report form defined with respect transaction contemplated under this agreement filing supplemental information requested connection therewith pursuant which form shall specifically request early termination waiting period prescribed each party shall furnish other party counsel such necessary information reasonable assistance other party counsel request connection with preparation filing submission that necessary under connection with this agreement style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp action party each party shall commercially reasonable effort promptly obtain clearance required under consummation this agreement transaction contemplated hereby shall keep each other apprised status communication with inquiry request additional information from shall comply promptly with such inquiry request provided however that nbsp neither party shall required consent divestiture other disposition affiliate asset those other party agree material modification amendment this agreement nbsp neither party shall have obligation contest administratively court ruling order other action private party respecting transaction contemplated this agreement comply with other structure conduct remedy restriction limit operation provided further that party shall both commercially reasonable effort promptly respond request additional information defined under style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp expense each party shall responsible cost expense associated with filing each party shall responsible style font size vertical align style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify filing other than penalty that incurred result action omission part party which shall responsibility such party required paid connection with submitting such filing style margin margin bottom font size font family time roman align center article xiii style margin margin bottom font size font family time roman align center miscellaneous style margin margin bottom text indent font size font family time roman align justify section nbsp force majeure party shall held liable responsible other party deemed have defaulted under breached this agreement failure delay fulfilling performing term this agreement when such failure delay caused result from following cause beyond reasonable control affected party fire flood earthquake tsunami tornado hurricane windstorm eruption explosion sabotage vandalism embargo whether declared invasion domestic foreign terrorist public enemy insurrection riot civil commotion strike lockout other labor disturbance omission delay acting governmental authority each event force majeure provided that such affected party shall provide other party with prompt notice circumstance surrounding such material failure delay will commercially reasonable effort overcome difficulty created thereby resume performance obligation soon practicable performance such obligation under this agreement delayed owing such force majeure continuous period more than hundred eighty nbsp party will consult with respect equitable solution including possibility mutual termination this agreement avoidance doubt occurrence event force majeure shall relieve party from fulfilling obligation required hereunder rather period performance such obligation shall tolled during occurrence such force majeure style margin margin bottom text indent font size font family time roman align justify section nbsp notice notice request approval consent required permitted given party shall writing shall party address listed below such other address such party will have last given notice other party shall deemed have been sufficiently given when delivered person express courier service signature required five nbsp after sent registered letter return receipt requested equivalent provided that postal strike other disruption then effect come into effect within nbsp after such mailing style font size margin margin bottom nbsp align right table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width style font family time roman font size valign nbsp nbsp pfenex nbsp valign bottom valign align justify style font family time roman font size pfenex style font family time roman font size valign valign bottom valign style margin margin bottom font size font family time roman align justify roselle street style margin margin bottom font size font family time roman align justify diego style margin margin bottom font size font family time roman align justify attention patrick lucy chief business officer style margin margin bottom font size font family time roman align justify style margin margin bottom font size font family time roman align justify paul wagner chief financial officer style font size height height colspan style font family time roman font size valign align justify style font family time roman font size with nbsp copy nbsp nbsp nbsp nbsp nbsp valign bottom valign align justify style font family time roman font size wilson sonsini goodrich nbsp rosati style font family time roman font size valign valign bottom valign style margin margin bottom font size font family time roman align justify page mill road style margin margin bottom font size font family time roman align justify palo alto style margin margin bottom font size font family time roman align justify attention edvalson table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center align right table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width style font family time roman font size valign nbsp nbsp hospira nbsp nbsp nbsp nbsp nbsp valign bottom valign style margin margin bottom font size font family time roman align justify hospira bahamas biologics style font family time roman font size valign valign bottom valign style margin margin bottom font size font family time roman north field drive style margin margin bottom font size font family time roman lake forest illinois style margin margin bottom font size font family time roman attention cole pinnow style font size height height colspan style font family time roman font size valign with nbsp copy nbsp valign bottom valign align justify style font family time roman font size hospira bahamas biologics style font family time roman font size valign valign bottom valign style margin margin bottom font size font family time roman north field drive style margin margin bottom font size font family time roman building department nleg style margin margin bottom font size font family time roman lake forest illinois style margin margin bottom font size font family time roman attention general counsel style font size height height colspan style font family time roman font size valign valign bottom valign align justify style font family time roman font size katten muchin rosenman style font family time roman font size valign valign bottom valign style margin margin bottom font size font family time roman west monroe street style margin margin bottom font size font family time roman chicago illinois style margin margin bottom font size font family time roman attention mark wood table style margin margin bottom text indent font size font family time roman align justify section nbsp governing this agreement shall construed governed interpreted applied accordance with state york without giving effect conflict principle style margin margin bottom text indent font size font family time roman align justify section nbsp arbitration style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp party unable resolve dispute under section nbsp then party agree that dispute kind nature except those described section nbsp shall resolved exclusively pursuant alternative dispute resolution term condition forth exhibit provided that judgment upon arbitral award confirmed entered court having competent jurisdiction over party their asset determination resulting from such alternative dispute resolution shall final binding appealable purpose this agreement nothing section nbsp this section nbsp shall limit party right seek obtain such alternative dispute resolution equitable relief which such party entitled hereunder style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp notwithstanding section nbsp section nbsp application emergency temporary injunctive relief party shall subject internal dispute resolution under section nbsp alternative dispute resolution under section nbsp provided however that remainder such dispute beyond application emergency temporary injunctive relief shall subject internal dispute resolution under section nbsp alternative dispute resolution under section nbsp applicable style margin margin bottom text indent font size font family time roman align justify section nbsp relationship party relationship party under this agreement that independent contractor nothing contained this agreement shall performance obligation under this agreement create association partnership joint venture relationship principal agent master servant employer employee between party party express implied right authority under this agreement assume create obligation make representation warranty behalf name other party such other party affiliate style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify section nbsp assignment neither party assign transfer sublicense right obligation under this agreement without prior written consent other party such consent unreasonable withheld conditioned delayed provided however that nbsp party assign this agreement whole part without such consent affiliate such party third party successor merger acquisition sale substantially such party asset upon written notice other party such assignment case assignment affiliate such party hereby guarantee performance such affiliate case third party assignment such third party shall assume obligation covenant shall make representation assigning party under this agreement nbsp hospira assign this agreement whole part without such consent third party that purchase biologics division parent that purchase substantially parent ophthalmic product upon written notice pfenex such assignment such third party shall assume obligation covenant shall make representation hospira under this agreement except expressly provided this section nbsp attempted assignment transfer this agreement shall null void style margin margin bottom text indent font size font family time roman align justify section nbsp binding effect this agreement shall binding upon shall inure benefit party their respective permitted successor assigns their signature hereto each party intends hereby become bound style margin margin bottom text indent font size font family time roman align justify section nbsp entire agreement amendment this agreement guaranty common interest agreement that certain memorandum exchanged between party signature date referencing this agreement schedule exhibit hereto thereto contain entire understanding party case guaranty pfenex parent with respect subject matter herein cancel previous agreement oral written negotiation discussion dealing with same subject matter party from time time during term modify provision hereof only instrument writing duly executed party style margin margin bottom text indent font size font family time roman align justify section nbsp severability part part this agreement held illegal void ineffective remaining portion this agreement shall remain full force effect term provision conflict with applicable then such term provision shall deemed inoperative extent that they conflict therewith shall deemed modified conformed with such applicable event ambiguity respecting term term hereof party agree construe interpret such ambiguity good faith such appropriate ensure enforceability viability exclusive remedy provided hereunder determined unenforceable then party entitled such remedy shall lieu thereof entitled such other remedy available such party under this agreement equity under applicable subject case limitation imposed other term this agreement style margin margin bottom text indent font size font family time roman align justify section nbsp rule construction interpretation this agreement shall governed following rule construction nbsp word singular shall held include plural vice versa word gender shall held include other gender context requires nbsp reference term article section paragraph exhibit schedule style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify reference article section paragraph exhibit schedule this agreement unless otherwise specified nbsp reference dollar mean united state dollar nbsp word including word similar import mean including without limitation unless otherwise specified nbsp word shall have meaning associated with phrase exclusive unless otherwise specified nbsp provision shall apply when appropriate successive event transaction nbsp reference person includes such person successor permitted assigns nbsp this agreement shall construed without regard presumption rule requiring construction interpretation against party drafting causing instrument drafted nbsp word mean calendar unless otherwise specified nbsp word notice mean notice writing whether specifically stated shall include notice consent approval other communication contemplated under this agreement nbsp each accounting term otherwise defined this agreement meaning assigned accordance with gaap nbsp word hereof herein hereby derivative similar word refer this agreement including exhibit nbsp provision that require that party party executive steering committee agree consent approve like shall require that such agreement consent approval specific writing whether written agreement letter approved minute otherwise nbsp reference specific rule regulation article section other division thereof shall deemed include then current amendment thereto replacement rule regulation thereof nbsp unless otherwise specified activity conducted party under this agreement shall such party cost expense nbsp neither party affiliate shall deemed acting behalf other party hereunder exhibit referred herein hereby incorporated reference heading contained this agreement used only matter convenience define limit construe describe scope intent section this agreement style margin margin bottom text indent font size font family time roman align justify section nbsp waiver failure delay part party either exercising enforcing right under this agreement shall operate waiver impair such right single partial exercise enforcement such right shall preclude other further exercise enforcement thereof exercise enforcement other right waiver such right shall have effect unless given signed writing waiver such right shall deemed waiver other right style margin margin bottom text indent font size font family time roman align justify section nbsp counterpart this agreement executed multiple counterpart such executed counterpart shall constitute same agreement shall necessary account only such counterpart proving existence term this agreement style margin margin bottom text indent font size font family time roman align justify section nbsp electronic execution delivery facsimile other reproduction this agreement executed more party executed copy this agreement delivered more party facsimile mail other electronic transmission device pursuant which signature behalf such party seen such execution delivery shall considered valid binding effective purpose request party party agree execute original this agreement well facsimile reproduction thereof party hereby agree that party shall raise execution facsimile other reproduction this agreement fact that style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify signature document transmitted communicated facsimile mail other electronic transmission device defense formation this agreement style margin margin bottom text indent font size font family time roman align justify section nbsp license protection party acknowledge agree that each pfenex hospira shall entitled right protection forth section nbsp title united state code with respect license contained herein style margin margin bottom text indent font size font family time roman align justify section nbsp further assurance each party agrees execute acknowledge deliver such further instrument such other reasonably necessary appropriate order carry purpose intent this agreement style margin margin bottom text indent font size font family time roman align justify section nbsp compliance with applicable each party shall comply with applicable governing performance term this agreement style margin margin bottom text indent font size font family time roman align justify section nbsp expense except otherwise expressly forth herein each party shall cost expense incident negotiation preparation this agreement performance compliance with obligation contained herein part performed complied with including expense disbursement counsel other advisor style margin margin bottom text indent font size font family time roman align justify section nbsp third party beneficiary nothing herein expressed implied intended shall construed confer upon give person other than party their respective permitted successor assigns right remedy under reason this agreement except contemplated term article style margin margin bottom text indent font size font family time roman align justify section nbsp equitable remedy each party acknowledges that breach threatened breach such party obligation under this agreement give rise irreparable harm other party which monetary damage adequate remedy hereby agrees that event such breach threatened breach party such obligation other party suffering such harm shall addition other right remedy that available respect such breach entitled seek equitable relief including temporary restraining order injunction specific performance subject case section without obligation post bond style margin margin bottom font size font family time roman align center signature page follows style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify witness whereof party have caused this agreement executed signature date style font size margin margin bottom nbsp align right table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width style font family time roman font size valign colspan pfenex style font size height height colspan style font family time roman font size valign align justify style font family time roman font size valign bottom valign style margin margin bottom border bottom solid font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp bertrand liang style font family time roman font size valign colspan style margin margin bottom font size font family time roman align justify name nbsp bertrand liang style margin margin bottom font size font family time roman align justify title chief executive officer style font size height colspan style font family time roman font size valign colspan hospira nbsp bahamas nbsp biologics nbsp style font size height height colspan style font family time roman font size valign align justify style font family time roman font size valign bottom valign style margin margin bottom border bottom solid font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp richard hoffman style font family time roman font size valign colspan style margin margin bottom font size font family time roman align justify name richard hoffman style margin margin bottom font size font family time roman align justify title sole director table style margin margin bottom font size font family time roman align center signature page development license agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center major market style margin margin bottom font size font family time roman united state style margin margin bottom font size font family time roman canada style margin margin bottom font size font family time roman france style margin margin bottom font size font family time roman germany style margin margin bottom font size font family time roman spain style margin margin bottom font size font family time roman united kingdom style margin margin bottom font size font family time roman italy style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style page break before always size style color width align center style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center press release style margin margin bottom font size font family time roman attached style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style page break before always size style color width align center style margin margin bottom logo style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family arial font size align center width valign bottom width width style font family arial font size valign align justify style font family arial font size draft february valign bottom valign align justify style font family arial font size immediate release table style margin margin bottom font size font family arial align center pfenex hospira announce collaboration develop style margin margin bottom font size font family arial align center commercialize proposed lucentis style font size vertical align biosimilar style margin margin bottom font size font family arial diego lake forest february pfenex nyse pfnx clinical stage biotechnology company engaged development biosimilar therapeutic hospira nyse world leading provider injectable drug infusion technology global leader biosimilars today announced that company have entered into agreement exclusively develop commercialize worldwide sale pfenex biosimilar candidate genentech lucentis style font size vertical align ranibizumab injection lucentis estimated global sale approximately billion part broader billion intraocular anti vegf vascular endothelial growth factor therapeutic segment style margin margin bottom font size font family arial under term collaboration pfenex will receive upfront payment million once collaboration receives antitrust approval over next five year beyond will eligible receive combination development sale based milestone payment additional million tiered double digit royalty sale product style margin margin bottom font size font family arial pfenex hospira will share phase equivalence clinical trial cost hospira will responsible manufacturing commercializing product worldwide collaboration will governed executive steering committee consisting equal representation from pfenex hospira agreement also allows additional future product collaboration style margin margin bottom font size font family arial extremely pleased announce collaboration with hospira recognized world leader biosimilars this collaboration further validates product development strength capability pfenex continue advance pipeline biosimilar candidate said bertrand liang chief executive officer pfenex style margin margin bottom font size font family arial pfenex currently conducting phase clinical trial where patient have been randomized receive monthly intraocular injection lucentis style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom logo style margin margin bottom font size font family time roman style margin margin bottom font size font family arial align center more style page break before always size style color width align center style margin margin bottom font size font family arial align center pfenex hospira announce collaboration develop style margin margin bottom font size font family arial align center commercialize proposed lucentis style font size vertical align biosimilar page style margin margin bottom font size nbsp style margin margin bottom font size font family arial ongoing patient follow month clinical trial primary objective evaluate safety tolerability with secondary objective including comparative pharmacokinetic pharmacodynamic evaluation help demonstrate biosimilarity lucentis style margin margin bottom font size font family arial excited entering this collaboration with pfenex biosimilar candidate lucentis which expect will expand hospira biosimilars pipeline include therapeutic area pfenex established expertise development biosimilars leveraging proprietary expression technology together with differentiated bioanalytical characterization capability said sumant ramachandra senior vice president chief scientific officer hospira look forward working closely with pfenex team offer patient physician healthcare system more affordable treatment option retinal disease style margin margin bottom font size font family arial agreement subject review under hart scott rodino antitrust improvement style margin margin bottom font size font family arial about pfenex style margin margin bottom font size font family arial pfenex clinical stage biotechnology company engaged development biosimilar therapeutic high value difficult manufacture protein company lead product candidate biosimilar candidate lucentis ranibizumab potential treatment patient with retinal disease pfenex leveraged expression technology style font size vertical align platform build pipeline product candidate preclinical product under development including other biosimilars well vaccine generic next generation biologics style margin margin bottom font size font family arial pfenex used intends continue investor relation website http pfenex investorroom mean disclosing material public information complying with disclosure obligation under regulation more information visit http pfenex investorroom style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom logo style margin margin bottom font size font family arial align center more style page break before always size style color width align center style margin margin bottom font size font family arial align center pfenex hospira announce collaboration develop style margin margin bottom font size font family arial align center commercialize proposed lucentis style font size vertical align biosimilar page style margin margin bottom font size nbsp style margin margin bottom font size font family arial about hospira style margin margin bottom font size font family arial hospira world leading provider injectable drug infusion technology global leader biosimilars through broad integrated portfolio hospira uniquely positioned advance wellnesstm improving patient caregiver safety while reducing healthcare cost company headquartered lake forest learn more hospira style margin margin bottom font size font family arial align center private security litigation reform style margin margin bottom font size font family arial align center caution concerning forward looking statement style margin margin bottom font size font family arial this press release contains forward looking statement within meaning section nbsp security section nbsp security exchange forward looking statement generally relate future event pfenex hospira future financial operating performance some case identify forward looking statement because they contain word such will should expects plan anticipates could intends target project contemplates belief estimate predicts potential continue negative these word other similar term expression that concern either pfenex hospira expectation strategy plan intention forward looking statement this press release include limited case pfenex statement regarding future potential including future plan develop manufacture commercialize potential receive future milestone royalty payment case hospira expectation regarding regulatory approval clinical trial action competitor company expectation belief regarding these matter materialize actual result future period subject risk uncertainty that could cause actual result differ materially from those projected actual result differ materially from those indicated these forward looking statement result various important factor including without limitation challenge inherent creating developing compound product candidate economic competitive governmental regulatory legal supply other factor information these additional risk affecting hospira business operating result more fully discussed section entitled risk factor most recently filed annual report form updated subsequently filed quarterly report form information these additional risk affecting pfenex business operating result more fully discussed section entitled risk factor most recently filed quarterly report form quarter ended september nbsp pfenex subsequent periodic report including pfenex form year ended december nbsp which expected filed with march forward looking statement this press release based information available date hergeof each pfenex hospira disclaims obligation update forward looking statement except required style margin margin bottom font size font family arial align center style margin margin bottom font size font family arial align justify pfenex contact table cellspacing cellpadding width border style border collapse collapse font family arial font size align center width valign bottom width width style font family arial font size valign align justify style font family arial font size paul wagner valign bottom valign westwicke partner style font family arial font size valign align justify style font family arial font size chief financial officer valign bottom valign robert style font family arial font size valign valign bottom valign managing director style font family arial font size valign valign bottom valign table style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom logo style margin margin bottom font size font family arial align center more style page break before always size style color width align center style margin margin bottom font size font family arial align center pfenex hospira announce collaboration develop style margin margin bottom font size font family arial align center commercialize proposed lucentis style font size vertical align biosimilar page style margin margin bottom font size nbsp style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family arial font size align center width valign bottom width width style font family arial font size valign align justify style font family arial font size hospira nbsp investor nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp valign bottom valign align justify style font family arial font size hospira medium style font family arial font size valign karen king valign bottom valign lauren spangler style font family arial font size valign valign bottom valign table style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style margin margin bottom font size nbsp style margin margin bottom logo style font size margin margin bottom nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center alternative dispute resolution style margin margin bottom text indent font size font family time roman align justify party recognize that bona fide dispute certain matter arise from time time during term this agreement which relate party right obligation have such dispute resolved this alternative dispute resolution provision party first must comply with section nbsp agreement which this exhibit matter been resolved accordance with such section nbsp party initiate proceeding provided herein party shall have right represented counsel such proceeding style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp begin proceeding party shall provide written notice other party issue resolved accordance with this exhibit within fourteen nbsp after receipt such notice other party written notice party initiating additional issue resolved within same style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp unless either party request otherwise writing within fourteen nbsp period described paragraph above issue shall resolved accordance with fast track meditation arbitration rule procedure administered institute dispute resolution single arbitrator appointed accordance with such rule subject provision paragraph below otherwise such dispute shall resolved described paragraph herein below style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp within twenty nbsp following receipt original notice party shall select mutually acceptable neutral neutral preside resolution dispute this proceeding party unable agree mutually acceptable neutral within such period party request president madison avenue floor york york select neutral pursuant following procedure style margin margin bottom margin left text indent font size font family time roman align justify nbsp nbsp nbsp nbsp shall submit party list than five nbsp candidate within fourteen nbsp after receipt request along with curriculum vitae each candidate candidate shall employee director shareholder party their subsidiary affiliate each candidate submitted shall nbsp attorney licensed practice least twenty nbsp year united state nbsp have material legal business experience pharmaceutical industry style margin margin bottom margin left text indent font size font family time roman align justify nbsp nbsp nbsp nbsp such list shall include statement disclosure each candidate circumstance likely affect impartiality style margin margin bottom margin left text indent font size font family time roman align justify nbsp nbsp nbsp nbsp each party shall number candidate order preference with number nbsp signifying greatest preference shall deliver list within seven nbsp following receipt list candidate party belief conflict interest exists regarding candidate that party shall provide written explanation conflict along with list showing order style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style page break before always size style color width align center style margin margin bottom margin left font size font family time roman align justify preference candidate party failing return list preference time shall deemed have order preference style margin margin bottom margin left text indent font size font family time roman align justify nbsp nbsp nbsp nbsp party collectively have identified fewer than three nbsp candidate deemed have conflict immediately shall designate neutral candidate whom party collectively have indicated greatest preference should result between candidate designate either candidate party collectively have identified three nbsp more candidate deemed have conflict shall review explanation regarding conflict sole discretion either nbsp immediately designate neutral candidate whom party collectively have indicated greatest preference nbsp issue list than five nbsp candidate which case procedure forth subparagraphs shall repeated style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp earlier than forty five nbsp later than ninety nbsp after selection neutral shall hold hearing resolve each issue identified party proceeding shall take place location agreed upon party party agree neutral shall designate following four city immediate environs york york atlanta georgia washington wilmington delaware style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp least fourteen nbsp prior hearing each party shall submit following other party neutral style margin margin bottom margin left text indent font size font family time roman align justify nbsp nbsp nbsp nbsp copy exhibit which such party intends rely oral written presentation neutral style margin margin bottom margin left text indent font size font family time roman align justify nbsp nbsp nbsp nbsp list witness such party intends call hearing short summary anticipated testimony each witness style margin margin bottom margin left text indent font size font family time roman align justify nbsp nbsp nbsp nbsp proposed ruling each issue resolved together with request specific damage award other remedy each issue proposed ruling remedy shall contain recitation fact legal argument shall exceed nbsp page issue style margin margin bottom margin left text indent font size font family time roman align justify nbsp nbsp nbsp nbsp brief support such party proposed ruling remedy provided that brief shall exceed thirty nbsp double spaced page this page limitation shall apply regardless number issue raised proceeding style margin margin bottom font size font family time roman align justify except expressly forth subparagraphs discovery shall required permitted mean including deposition interrogatory request admission production document style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp hearing shall conducted consecutive shall governed style margin margin bottom font size font family time roman following rule style margin margin bottom margin left text indent font size font family time roman align justify each party shall entitled nbsp hour hearing time present case neutral shall determine whether each party nbsp hour which entitled style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style page break before always size style color width align center style margin margin bottom margin left text indent font size font family time roman align justify nbsp nbsp nbsp nbsp each party shall entitled required make opening statement present regular rebuttal testimony document other evidence cross examine witness make closing argument cross examination witness shall occur immediately after their direct testimony opening statement closing statement rebuttal testimony cross examination time shall charged against party conducting same style margin margin bottom margin left text indent font size font family time roman align justify nbsp nbsp nbsp nbsp party initiating shall begin hearing chooses make opening statement shall address only issue raised also issue raised responding party responding party chooses make opening statement also shall address issue raised thereafter presentation regular rebuttal testimony document other evidence closing argument shall proceed same sequence style margin margin bottom margin left text indent font size font family time roman align justify nbsp nbsp nbsp nbsp except when testifying witness shall excluded from hearing until closing argument style margin margin bottom margin left text indent font size font family time roman align justify nbsp nbsp nbsp nbsp settlement negotiation including statement made therein shall admissible under circumstance affidavit prepared purpose hearing also shall admissible live videoconference telephonic testimony will permitted discretion neutral neutral shall have sole discretion with regard exercise subpoena power compel attendance witness production document from third party other matter neutral shall have sole discretion regarding admissibility evidence style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp within nbsp following completion hearing each party submit other party neutral post hearing brief support proposed ruling remedy provided that such brief shall contain discus evidence shall exceed thirty nbsp page this page limitation shall apply regardless number issue raised proceeding style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp neutral shall rule each disputed issue within twenty nbsp following completion hearing such ruling shall adopt entirety proposed ruling remedy party each disputed issue adopt party proposed ruling remedy some issue other party proposed ruling remedy other issue neutral shall issue written opinion otherwise explain basis ruling style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp neutral shall paid reasonable plus expense these expense along with reasonable legal expense prevailing party including expert witness expense expense court reporter expense hearing room shall paid follows style margin margin bottom margin left text indent font size font family time roman align justify nbsp nbsp nbsp nbsp neutral rule favor party disputed issue losing party shall hundred percent nbsp such expense style margin margin bottom margin left text indent font size font family time roman align justify nbsp nbsp nbsp nbsp neutral rule favor party some issue other party other issue neutral shall issue with ruling written determination style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style page break before always size style color width align center style margin margin bottom margin left font size font family time roman align justify such expense shall allocated between party neutral shall allocate expense that bear reasonable relationship outcome with party prevailing more issue issue greater value gravity recovering relatively larger share legal expense style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp ruling neutral allocation expense shall binding reviewable appealable extent allowed entered final judgment court having jurisdiction style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp except provided paragraph required applicable existence dispute settlement negotiation hearing submission including exhibit testimony proposed ruling brief ruling shall deemed confidential information both party neutral shall have authority impose sanction unauthorized disclosure confidential information style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp neutral award punitive damage party hereby waive right award punitive damage style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp hearing shall conducted english language style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align justify certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion body html text document